RxNorm Semantic Concepts Index - 274
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "274".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 274 | Actomyosin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740000 | nusinersen 5.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2740001 | nusinersen 28 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740001 | nusinersen 28 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740001 | nusinersen 28 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740002 | nusinersen 5.6 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740002 | nusinersen 5.6 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740003 | nusinersen 5.6 MG/ML [Spinraza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740004 | SPINRAZA 28 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740004 | SPINRAZA 28 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740004 | SPINRAZA 28 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740005 | SPINRAZA 5.6 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2740005 | SPINRAZA 5.6 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740005 | SPINRAZA 5.6 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740006 | terbinafine / undecylenate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2740007 | terbinafine / undecylenate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2740008 | terbinafine / undecylenate Topical Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2740011 | terbinafine hydrochloride 1 % / undecylenic acid 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740011 | terbinafine hydrochloride 1 % / undecylenic acid 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740011 | terbinafine hydrochloride 1 % / undecylenic acid 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740012 | tividenofusp alfa | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2740013 | tividenofusp alfa-eknm | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2740014 | tividenofusp alfa-eknm 150 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2740015 | tividenofusp alfa Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2740016 | tividenofusp alfa Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2740019 | tividenofusp alfa-eknm 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740019 | tividenofusp alfa-eknm 150 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740020 | Avlayah | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2740021 | tividenofusp alfa-eknm 150 MG [Avlayah] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740022 | Avlayah Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2740023 | tividenofusp alfa Injection [Avlayah] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2740025 | AVLAYAH 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740025 | AVLAYAH 150 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740025 | AVLAYAH 150 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 27403 | ifenprodil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 27403 | ifenprodil | Designated preferred name (PT) | NO | |
| RxCUI: 27403 | ifenprodil | Full form of descriptor (FN) | NO | |
| RxCUI: 2740381 | methyl salicylate 30 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740381 | methyl salicylate 30 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740381 | methyl salicylate 30 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740382 | marnetegragene autotemcel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2740383 | marnetegragene autotemcel 6100000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2740384 | marnetegragene autotemcel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2740385 | marnetegragene autotemcel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2740386 | marnetegragene autotemcel 6,100,000 CELLS/ML in 30 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740386 | marnetegragene autotemcel 6,100,000 CELLS/ML in 30 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740386 | marnetegragene autotemcel 6,100,000 CELLS/ML in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740387 | marnetegragene autotemcel 6100000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740388 | Kresladi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2740389 | marnetegragene autotemcel 6100000 CELLS/ML [Kresladi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740390 | Kresladi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2740391 | marnetegragene autotemcel Injection [Kresladi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2740392 | KRESLADI 6,100,000 CELLS/ML in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740392 | KRESLADI 6,100,000 CELLS/ML in 30 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740392 | KRESLADI 6,100,000 CELLS/ML in 30 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740392 | KRESLADI 6,100,000 CELLS/ML in 30 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740393 | marnetegragene autotemcel 6100000 CELLS/ML Injection [Kresladi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740393 | marnetegragene autotemcel 6100000 CELLS/ML Injection [Kresladi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2740394 | Insulin icodec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2740394 | Insulin icodec | Designated preferred name (PT) | YES | |
| RxCUI: 2740394 | Insulin icodec | Full form of descriptor (FN) | YES | |
| RxCUI: 2740395 | insulin icodec-abae | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2740396 | insulin icodec-abae 700 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2740397 | insulin icodec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2740398 | insulin icodec Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2740401 | insulin icodec-abae 700 UNT in 1 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740401 | insulin icodec-abae 700 UNT in 1 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740401 | insulin icodec-abae 700 UNT in 1 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740402 | insulin icodec-abae 700 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740403 | Awiqli | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2740404 | insulin icodec-abae 700 UNT/ML [Awiqli] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740405 | Awiqli Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2740406 | insulin icodec Pen Injector [Awiqli] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2740408 | Awiqli 700 UNT in 1 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740408 | Awiqli 700 UNT in 1 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740408 | Awiqli 700 UNT in 1 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740408 | Awiqli 700 UNT in 1 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740409 | insulin icodec-abae 700 UNT/ML Pen Injector [Awiqli] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740409 | insulin icodec-abae 700 UNT/ML Pen Injector [Awiqli] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2740410 | insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740410 | insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740410 | insulin icodec-abae 1050 UNT in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740411 | Awiqli 1050 UNT in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740411 | Awiqli 1050 UNT in 1.5 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740411 | Awiqli 1050 UNT in 1.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740411 | Awiqli 1050 UNT in 1.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740412 | insulin icodec-abae 2100 UNT in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740412 | insulin icodec-abae 2100 UNT in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740412 | insulin icodec-abae 2100 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740413 | Awiqli 2100 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740413 | Awiqli 2100 UNT in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740413 | Awiqli 2100 UNT in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740413 | Awiqli 2100 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740414 | menthol 46 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2740415 | menthol 4.6 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740415 | menthol 4.6 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740415 | menthol 4.6 % Topical Lotion | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740416 | Capsicum extract 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2740417 | Capsicum extract 0.5 % / menthol 10 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740417 | Capsicum extract 0.5 % / menthol 10 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740417 | Capsicum extract 0.5 % / menthol 10 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740798 | ustekinumab-stba 45 MG in 0.5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740798 | ustekinumab-stba 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740798 | ustekinumab-stba 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740799 | ustekinumab-stba 90 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740799 | ustekinumab-stba 90 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740800 | SteQeyma 45 MG in 0.5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740800 | SteQeyma 45 MG in 0.5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740800 | SteQeyma 45 MG in 0.5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740801 | SteQeyma 90 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740801 | SteQeyma 90 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740801 | SteQeyma 90 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2740802 | clonidine hydrochloride 0.05 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2740802 | clonidine hydrochloride 0.05 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2740803 | cloNIDine hydrochloride 0.05 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740803 | cloNIDine hydrochloride 0.05 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740803 | cloNIDine hydrochloride 0.05 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2740803 | cloNIDine hydrochloride 0.05 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740803 | cloNIDine hydrochloride 0.05 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2740835 | camphor 5 % / capsaicin 0.025 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740835 | camphor 5 % / capsaicin 0.025 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740835 | camphor 5 % / capsaicin 0.025 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740838 | gabapentin 300 MG [Relgaabi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740839 | Relgaabi 300 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740839 | Relgaabi 300 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740839 | Relgaabi 300 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740840 | gabapentin 400 MG [Relgaabi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740841 | Relgaabi 400 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740841 | Relgaabi 400 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740841 | Relgaabi 400 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740861 | camphor 0.1 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740861 | camphor 0.1 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740861 | camphor 0.1 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2740862 | Nicotine (as nicotine bitartrate) 2 mg oromucosal lozenge | Designated preferred name (PT) | NO | |
| RxCUI: 2740862 | Nicotine (as nicotine bitartrate) 2 mg oromucosal lozenge | Full form of descriptor (FN) | NO | |
| RxCUI: 2740863 | sodium fluoride 2.7 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740863 | sodium fluoride 2.7 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740863 | sodium fluoride 2.7 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740863 | sodium fluoride 2.7 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740864 | Topicaine Ultra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2740865 | lidocaine hydrochloride 0.02 MG/MG [Topicaine Ultra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2740866 | Topicaine Ultra Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2740867 | lidocaine Topical Gel [Topicaine Ultra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2740869 | Topicaine Ultra 2 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2740869 | Topicaine Ultra 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740869 | Topicaine Ultra 2 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740869 | Topicaine Ultra 2 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740871 | Morphine hydrochloride 15 mg rectal suppository | Designated preferred name (PT) | NO | |
| RxCUI: 2740871 | Morphine hydrochloride 15 mg rectal suppository | Full form of descriptor (FN) | NO | |
| RxCUI: 2740924 | Gastrobim | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2740925 | omeprazole 0.37 MG/MG [Gastrobim] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2740926 | Gastrobim Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2740927 | Gastrobim Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2740928 | Gastrobim Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2740929 | omeprazole Oral Paste [Gastrobim] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2740930 | Gastrobim 37 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2740930 | Gastrobim 37 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2740930 | Gastrobim 37 % Oral Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2740931 | rocuronium Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2740933 | rocuronium bromide 50 MG in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2740933 | rocuronium bromide 50 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2740933 | rocuronium bromide 50 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2740934 | rocuronium bromide 10 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741039 | salicylic acid 400 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741040 | salicylic acid 40 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741040 | salicylic acid 40 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741040 | salicylic acid 40 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741043 | methenamine Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741045 | methenamine mandelate 500 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741045 | methenamine mandelate 500 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741045 | methenamine mandelate 500 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741131 | potassium nitrate 5 % / sodium fluoride 0.221 % (fluoride ion 0.10 % ) Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741131 | potassium nitrate 5 % / sodium fluoride 0.221 % (fluoride ion 0.10 % ) Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741131 | potassium nitrate 5 % / sodium fluoride 0.221 % (fluoride ion 0.10 % ) Toothpaste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741131 | potassium nitrate 5 % / sodium fluoride 0.221 % (fluoride ion 0.10 % ) Toothpaste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741131 | potassium nitrate 5 % / sodium fluoride 0.221 % (fluoride ion 0.10 % ) Toothpaste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741179 | benzalkonium chloride 0.00405 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741180 | cypermethrin 0.0025 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741181 | polihexanide 0.0003 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741182 | benzalkonium / cypermethrin / polihexanide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2741183 | benzalkonium / cypermethrin / polihexanide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2741184 | benzalkonium / cypermethrin / polihexanide Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2741187 | benzalkonium chloride 0.405 GM / cypermethrin 0.25 GM / polihexanide 0.03 GM in 100 GM Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741187 | benzalkonium chloride 0.405 GM / cypermethrin 0.25 GM / polihexanide 0.03 GM in 100 GM Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741187 | benzalkonium chloride 0.405 GM / cypermethrin 0.25 GM / polihexanide 0.03 GM in 100 GM Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741188 | benzalkonium chloride 4.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741189 | cypermethrin 2.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741190 | polihexanide 0.3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741191 | benzalkonium / cypermethrin / polihexanide Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2741193 | benzalkonium chloride 0.405 GM / cypermethrin 0.25 GM / polyhexanide 0.03 GM in 100 mL Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741193 | benzalkonium chloride 0.405 GM / cypermethrin 0.25 GM / polyhexanide 0.03 GM in 100 mL Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741193 | benzalkonium chloride 0.405 GM / cypermethrin 0.25 GM / polyhexanide 0.03 GM in 100 mL Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741362 | salicylic acid 0.2 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741363 | salicylic acid 20 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741363 | salicylic acid 20 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741363 | salicylic acid 20 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741364 | dexchlorpheniramine / dextromethorphan | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2741365 | dexchlorpheniramine / dextromethorphan Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2741366 | dexchlorpheniramine / dextromethorphan Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2741367 | dexchlorpheniramine / dextromethorphan Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741371 | dexchlorpheniramine maleate 1 MG / dextromethorphan HBr 10 MG in 5 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741371 | dexchlorpheniramine maleate 1 MG / dextromethorphan HBr 10 MG in 5 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741371 | dexchlorpheniramine maleate 1 MG / dextromethorphan HBr 10 MG in 5 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741387 | cetylpyridinium chloride 0.27 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2741388 | cetylpyridinium chloride 0.027 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741388 | cetylpyridinium chloride 0.027 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741388 | cetylpyridinium chloride 0.027 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741464 | Hyoscyamine sulfate 375 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2741464 | Hyoscyamine sulfate 375 microgram oral tablet | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741464 | Hyoscyamine sulfate 375 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2741467 | zinc pyrithione 0.125 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741467 | zinc pyrithione 0.125 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741467 | zinc pyrithione 0.125 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741468 | anifrolumab Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741470 | anifrolumab-fnia 120 MG in 0.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741470 | anifrolumab-fnia 120 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741470 | anifrolumab-fnia 120 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741471 | anifrolumab-fnia 150 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741471 | anifrolumab-fnia 150 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741472 | anifrolumab Auto-Injector [Saphnelo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2741474 | Saphnelo 120 MG in 0.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741474 | Saphnelo 120 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741474 | Saphnelo 120 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741475 | Saphnelo 150 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2741475 | Saphnelo 150 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741475 | Saphnelo 150 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741476 | anifrolumab Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741478 | anifrolumab-fnia 120 MG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741478 | anifrolumab-fnia 120 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741478 | anifrolumab-fnia 120 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741479 | anifrolumab-fnia 150 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741479 | anifrolumab-fnia 150 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741480 | anifrolumab Prefilled Syringe [Saphnelo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2741482 | Saphnelo 120 MG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741482 | Saphnelo 120 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741482 | Saphnelo 120 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741483 | Saphnelo 150 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2741483 | Saphnelo 150 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741483 | Saphnelo 150 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741484 | eplontersen Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741485 | eplontersen 45 MG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741485 | eplontersen 45 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741485 | eplontersen 45 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741486 | eplontersen 56.3 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741486 | eplontersen 56.3 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741487 | eplontersen Prefilled Syringe [Wainua] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2741488 | WAINUA 45 MG in 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741488 | WAINUA 45 MG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741488 | WAINUA 45 MG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741489 | WAINUA 56.3 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2741489 | WAINUA 56.3 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741489 | WAINUA 56.3 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741609 | Ostirobe | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2741610 | robenacoxib 6 MG [Ostirobe] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2741611 | Ostirobe Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2741612 | Ostirobe Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2741613 | robenacoxib Oral Tablet [Ostirobe] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2741614 | OstiRobe 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741614 | OstiRobe 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741614 | OstiRobe 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2741615 | lunsotogene parvec-cwha | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2741616 | lunsotogene parvec | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2741617 | lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2741618 | lunsotogene parvec Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2741619 | lunsotogene parvec Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741622 | lunsotogene parvec-cwha 3.0 x 10(13) vg/ML in 0.63 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741622 | lunsotogene parvec-cwha 3.0 x 10(13) vg/ML in 0.63 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741622 | lunsotogene parvec-cwha 3.0 x 10(13) vg/ML in 0.63 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741623 | lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741623 | lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741623 | lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741624 | Otarmeni | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2741625 | lunsotogene parvec-cwha 30000000000000 VECTOR-GENOMES/ML [Otarmeni] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2741626 | Otarmeni Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2741627 | lunsotogene parvec Injection [Otarmeni] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2741629 | Otarmeni 3.0 x 10(13) vg/ML in 0.63 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741629 | Otarmeni 3.0 x 10(13) vg/ML in 0.63 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741629 | Otarmeni 3.0 x 10(13) vg/ML in 0.63 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741630 | Otarmeni 30000000000000 VECTOR-GENOMES/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2741630 | Otarmeni 30000000000000 VECTOR-GENOMES/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741630 | Otarmeni 30000000000000 VECTOR-GENOMES/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741631 | dapagliflozin 2,3-butanediol monohydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2741685 | urea 405 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2741686 | urea 40.5 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741686 | urea 40.5 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741686 | urea 40.5 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741687 | camphor 6 % / capsaicin 0.05 % / menthol 10 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741687 | camphor 6 % / capsaicin 0.05 % / menthol 10 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741687 | camphor 6 % / capsaicin 0.05 % / menthol 10 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741688 | islatravir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2741689 | islatravir 0.25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2741690 | doravirine / islatravir | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2741691 | doravirine / islatravir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2741692 | doravirine / islatravir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2741693 | doravirine / islatravir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2741694 | doravirine 100 MG / islatravir 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741694 | doravirine 100 MG / islatravir 0.25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741695 | Idvynso | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2741696 | doravirine 100 MG / islatravir 0.25 MG [Idvynso] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2741697 | Idvynso Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2741698 | Idvynso Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2741699 | doravirine / islatravir Oral Tablet [Idvynso] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2741700 | Idvynso 100 MG / 0.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741700 | Idvynso 100 MG / 0.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741700 | Idvynso 100 MG / 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741701 | dextromethorphan HBr 30 MG / buPROPion HCl 105 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741701 | dextromethorphan HBr 30 MG / buPROPion HCl 105 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2741701 | dextromethorphan HBr 30 MG / buPROPion HCl 105 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741701 | dextromethorphan HBr 30 MG / buPROPion HCl 105 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2741701 | dextromethorphan HBr 30 MG / buPROPion HCl 105 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741702 | bupropion hydrochloride 105 MG / dextromethorphan hydrobromide 30 MG [Auvelity] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2741702 | bupropion hydrochloride 105 MG / dextromethorphan hydrobromide 30 MG [Auvelity] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2741703 | Auvelity 30 MG / 105 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741703 | Auvelity 30 MG / 105 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2741703 | Auvelity 30 MG / 105 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741703 | Auvelity 30 MG / 105 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741703 | Auvelity 30 MG / 105 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2741704 | glycopyrrolate 0.018 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2741705 | budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT 28 ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741705 | budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT 28 ACTUAT Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741705 | budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT 28 ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741706 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.018 MG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2741707 | budesonide 0.16 MG/ACTUAT / formoterol fumarate 0.0048 MG/ACTUAT / glycopyrrolate 0.018 MG/ACTUAT [Breztri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2741708 | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 28 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741708 | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 28 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741708 | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 28 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741709 | budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT Metered Dose Inhaler | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2741709 | budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2741709 | budesonide 160 MCG/ACTUAT / glycopyrrolate 18 MCG/ACTUAT / formoterol fumarate 4.8 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2741710 | budesonide 160 MCG / glycopyrrolate 18 MCG / formoterol fumarate 4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2741710 | budesonide 160 MCG / glycopyrrolate 18 MCG / formoterol fumarate 4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2741710 | budesonide 160 MCG / glycopyrrolate 18 MCG / formoterol fumarate 4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741711 | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2741711 | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2741711 | BREZTRI 160/18/4.8 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27418 | Invariant chain | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27418 | Invariant chain | Designated preferred name (PT) | NO | |
| RxCUI: 27418 | Invariant chain | Full form of descriptor (FN) | NO | |
| RxCUI: 2742551 | Pellix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2742552 | calcipotriene 0.05 MG/ML [Pellix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2742553 | Pellix Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2742554 | calcipotriene Topical Solution [Pellix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2742555 | Pellix 0.005 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2742555 | Pellix 0.005 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2742555 | Pellix 0.005 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2742555 | Pellix 0.005 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2742556 | Evesse | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2742557 | hydrocortisone butyrate 1 MG/ML [Evesse] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2742558 | Evesse Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2742559 | hydrocortisone Topical Lotion [Evesse] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2742561 | EVESSE 0.1 % Topical Lotion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2742561 | EVESSE 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2742561 | EVESSE 0.1 % Topical Lotion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2742561 | EVESSE 0.1 % Topical Lotion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2742563 | sodium methyltaurate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2742640 | calcium carbonate 250 MG Oral Lozenge | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2742640 | calcium carbonate 250 MG Oral Lozenge | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 274275 | Human epididymis protein 4 | Designated preferred name (PT) | NO | |
| RxCUI: 274275 | Human epididymis protein 4 | Full form of descriptor (FN) | NO | |
| RxCUI: 2742847 | sodium hyaluronate 0.1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2742848 | hyaluronate Mucosal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2742849 | hyaluronate Mucosal Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2742852 | sodium hyaluronate 0.01 % Mucosal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2742852 | sodium hyaluronate 0.01 % Mucosal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2742852 | sodium hyaluronate 0.01 % Mucosal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2742853 | sodium hyaluronate 0.25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2742854 | hyaluronate Dental Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2742855 | hyaluronate Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2742856 | hyaluronate Mouthwash Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2742857 | hyaluronate Mouthwash | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2742862 | sodium hyaluronate 0.025 % Mouthwash | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2742862 | sodium hyaluronate 0.025 % Mouthwash | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2742862 | sodium hyaluronate 0.025 % Mouthwash | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2742999 | hyaluronate Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743000 | hyaluronate Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743004 | sodium hyaluronate 0.2 % Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743004 | sodium hyaluronate 0.2 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743004 | sodium hyaluronate 0.2 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743005 | melatonin 1.5 MG Extended Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743005 | melatonin 1.5 MG Extended Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743006 | kaempferol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2743007 | Anoectochilus roxburghii whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2743008 | meloxicam 0.5 MG/ML [Loxicom] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2743009 | Loxicom 0.5 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743009 | Loxicom 0.5 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743009 | Loxicom 0.5 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743010 | ruxolitinib 11 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743011 | ruxolitinib Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743012 | ruxolitinib 11 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743012 | ruxolitinib 11 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743012 | ruxolitinib 11 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743013 | ruxolitinib 11 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743013 | ruxolitinib 11 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743014 | ruxolitinib 11 MG [Jakafi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743015 | ruxolitinib Extended Release Oral Tablet [Jakafi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743016 | Jakafi XR 11 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743016 | Jakafi XR 11 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743016 | Jakafi XR 11 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743017 | Jakafi 11 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743017 | Jakafi 11 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743017 | Jakafi 11 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743018 | ruxolitinib 22 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743019 | ruxolitinib 22 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743019 | ruxolitinib 22 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743019 | ruxolitinib 22 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743020 | ruxolitinib 22 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743020 | ruxolitinib 22 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743021 | ruxolitinib 22 MG [Jakafi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743022 | Jakafi XR 22 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743022 | Jakafi XR 22 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743022 | Jakafi XR 22 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743023 | Jakafi 22 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743023 | Jakafi 22 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743023 | Jakafi 22 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743024 | ruxolitinib 33 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743025 | ruxolitinib 33 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743025 | ruxolitinib 33 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743025 | ruxolitinib 33 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743026 | ruxolitinib 33 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743026 | ruxolitinib 33 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743027 | ruxolitinib 33 MG [Jakafi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743028 | Jakafi XR 33 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743028 | Jakafi XR 33 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743028 | Jakafi XR 33 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743029 | Jakafi 33 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743029 | Jakafi 33 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743029 | Jakafi 33 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743031 | ruxolitinib 44 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743032 | ruxolitinib 44 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743032 | ruxolitinib 44 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743032 | ruxolitinib 44 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743033 | ruxolitinib 44 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743033 | ruxolitinib 44 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743034 | ruxolitinib 44 MG [Jakafi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743035 | Jakafi XR 44 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743035 | Jakafi XR 44 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743035 | Jakafi XR 44 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743036 | Jakafi 44 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743036 | Jakafi 44 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743036 | Jakafi 44 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743040 | ruxolitinib 55 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743041 | ruxolitinib 55 MG 24HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743041 | ruxolitinib 55 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743041 | ruxolitinib 55 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743042 | ruxolitinib 55 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743042 | ruxolitinib 55 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743043 | ruxolitinib 55 MG [Jakafi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743044 | Jakafi XR 55 MG 24HR Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743044 | Jakafi XR 55 MG 24HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743044 | Jakafi XR 55 MG 24HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743045 | Jakafi 55 MG Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743045 | Jakafi 55 MG Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743045 | Jakafi 55 MG Extended Release Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743046 | Amerithroid | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743047 | thyroid (USP) 120 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743048 | Amerithroid Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743049 | Amerithroid Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743050 | thyroid (USP) Oral Tablet [Amerithroid] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743051 | amerithroid 120 MG (2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743051 | amerithroid 120 MG (2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743051 | amerithroid 120 MG (2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743052 | thyroid (USP) 15 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743053 | amerithroid 15 MG (1/4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743053 | amerithroid 15 MG (1/4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743053 | amerithroid 15 MG (1/4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743054 | thyroid (USP) 30 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743055 | amerithroid 30 MG (1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743055 | amerithroid 30 MG (1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743055 | amerithroid 30 MG (1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743056 | thyroid (USP) 60 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743057 | amerithroid 60 MG (1 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743057 | amerithroid 60 MG (1 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743057 | amerithroid 60 MG (1 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743058 | thyroid (USP) 90 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743059 | amerithroid 90 MG (1 1/2 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743059 | amerithroid 90 MG (1 1/2 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743059 | amerithroid 90 MG (1 1/2 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743060 | thyroid (USP) 180 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743061 | amerithroid 180 MG (3 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743061 | amerithroid 180 MG (3 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743061 | amerithroid 180 MG (3 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743062 | thyroid (USP) 240 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743063 | amerithroid 240 MG (4 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743063 | amerithroid 240 MG (4 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743063 | amerithroid 240 MG (4 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743064 | thyroid (USP) 300 MG [Amerithroid] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743065 | amerithroid 300 MG (5 grain) Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743065 | amerithroid 300 MG (5 grain) Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743065 | amerithroid 300 MG (5 grain) Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743066 | chlorpheniramine / dextromethorphan Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2743068 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG in 10 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743068 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG in 10 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743068 | chlorpheniramine maleate 2 MG / dextromethorphan hydrobromide 15 MG in 10 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743069 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Suspension) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2743069 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Suspension) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2743069 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Suspension) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743069 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Suspension) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743069 | 1 daytime (dextromethorphan HBr 5 MG / guaiFENesin 100 MG in 5 mL Oral Suspension) / 1 nighttime (chlorpheniramine maleate 2 MG / dextromethorphan HBr 15 MG in 10 mL Oral Suspension) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2743070 | Brachiose | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743070 | Brachiose | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2743070 | Brachiose | Designated preferred name (PT) | NO | |
| RxCUI: 2743070 | Brachiose | Full form of descriptor (FN) | NO | |
| RxCUI: 2743151 | sodium hyaluronate 0.1 % Ophthalmic Drops | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743151 | sodium hyaluronate 0.1 % Ophthalmic Drops | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743152 | doxecitine 2000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743153 | doxribtimine 2000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743154 | doxecitine / doxribtimine Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743155 | doxecitine / doxribtimine Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743156 | doxecitine / doxribtimine Powder for Oral Solution | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743159 | doxecitine 2000 MG / doxribtimine 2000 MG [Kygevvi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743160 | doxecitine / doxribtimine Powder for Oral Solution [Kygevvi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743186 | Digenyx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743187 | hyoscyamine sulfate 0.125 MG [Digenyx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743188 | Digenyx Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743189 | Digenyx Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743190 | hyoscyamine Oral Tablet [Digenyx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743192 | Digenyx 0.125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743192 | Digenyx 0.125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743192 | Digenyx 0.125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743195 | cholecalciferol 250 MCG (10,000 UNT) / vitamin K2 (as menaquinone-7) 200 MCG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743195 | cholecalciferol 250 MCG (10,000 UNT) / vitamin K2 (as menaquinone-7) 200 MCG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743195 | cholecalciferol 250 MCG (10,000 UNT) / vitamin K2 (as menaquinone-7) 200 MCG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743196 | influenza A virus A/Astrakhan/3212/2020 (H5N8) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2743197 | influenza A virus (H5N8) antigen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2743198 | influenza A virus A/Astrakhan/3212/2020 (H5N8) antigen 0.0075 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743199 | influenza A virus (H5N8) antigen Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743200 | influenza A virus (H5N8) antigen Injectable Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743203 | influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743203 | influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743203 | influenza A (H5N8) virus vaccine (monovalent - Astrakhan/3212/2020) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743204 | Arepanrix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743205 | influenza A virus A/Astrakhan/3212/2020 (H5N8) antigen 0.0075 MG/ML [Arepanrix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743206 | Arepanrix Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743207 | influenza A virus (H5N8) antigen Injectable Suspension [Arepanrix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743209 | AREPANRIX vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743209 | AREPANRIX vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743209 | AREPANRIX vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743209 | AREPANRIX vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743250 | hypromellose 7 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2743251 | hypromellose 0.7 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743251 | hypromellose 0.7 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743251 | hypromellose 0.7 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743252 | Noxivent | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743253 | nitric oxide 0.08 % / nitrogen 99.92 % [Noxivent] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743254 | Noxivent Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743255 | nitric oxide / nitrogen Gas for Inhalation [Noxivent] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743256 | Noxivent 800 PPM Gas for Inhalation | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743256 | Noxivent 800 PPM Gas for Inhalation | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743256 | Noxivent 800 PPM Gas for Inhalation | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743257 | salicylic acid 27 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743257 | salicylic acid 27 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743257 | salicylic acid 27 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 274332 | nateglinide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 274332 | nateglinide | Designated preferred name (PT) | YES | |
| RxCUI: 274332 | nateglinide | Full form of descriptor (FN) | YES | |
| RxCUI: 274332 | nateglinide | Designated preferred name (PT) | YES | |
| RxCUI: 274332 | nateglinide | Full form of descriptor (FN) | YES | |
| RxCUI: 2743344 | Periogel | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2743345 | hydrogen peroxide 0.017 MG/MG [Periogel] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2743346 | Periogel Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2743347 | Periogel Oral Gel Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2743348 | hydrogen peroxide Oral Gel [Periogel] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2743349 | PerioGel 1.7 % Oral Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2743349 | PerioGel 1.7 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743349 | PerioGel 1.7 % Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743349 | PerioGel 1.7 % Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743350 | vepdegestrant | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2743351 | vepdegestrant 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743352 | vepdegestrant Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743353 | vepdegestrant Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743354 | vepdegestrant Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743355 | vepdegestrant 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743355 | vepdegestrant 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743356 | Veppanu | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743357 | vepdegestrant 100 MG [Veppanu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743358 | Veppanu Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743359 | Veppanu Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743360 | vepdegestrant Oral Tablet [Veppanu] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743361 | VEPPANU 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743361 | VEPPANU 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743361 | VEPPANU 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743362 | vepdegestrant 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743363 | vepdegestrant 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743363 | vepdegestrant 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743364 | vepdegestrant 200 MG [Veppanu] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743365 | VEPPANU 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743365 | VEPPANU 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743365 | VEPPANU 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743367 | chlorhexidine gluconate 0.2 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743367 | chlorhexidine gluconate 0.2 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743367 | chlorhexidine gluconate 0.2 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743368 | urea 20 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743368 | urea 20 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743368 | urea 20 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743369 | salicylic acid / selenium sulfide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2743370 | salicylic acid / selenium sulfide Shampoo Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2743371 | salicylic acid / selenium sulfide Medicated Shampoo | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2743372 | salicylic acid 2 % / selenium sulfide 1 % Medicated Shampoo | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743372 | salicylic acid 2 % / selenium sulfide 1 % Medicated Shampoo | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743372 | salicylic acid 2 % / selenium sulfide 1 % Medicated Shampoo | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743398 | baxdrostat | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2743398 | baxdrostat | Designated preferred name (PT) | YES | |
| RxCUI: 2743398 | baxdrostat | Full form of descriptor (FN) | YES | |
| RxCUI: 2743398 | baxdrostat | Designated preferred name (PT) | YES | |
| RxCUI: 2743398 | baxdrostat | Full form of descriptor (FN) | YES | |
| RxCUI: 2743399 | baxdrostat 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743400 | baxdrostat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743401 | baxdrostat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743402 | baxdrostat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743403 | baxdrostat 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743403 | baxdrostat 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743404 | Baxfendy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743405 | baxdrostat 1 MG [Baxfendy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743406 | Baxfendy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743407 | Baxfendy Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743408 | baxdrostat Oral Tablet [Baxfendy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743409 | BAXFENDY 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743409 | BAXFENDY 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743409 | BAXFENDY 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743410 | baxdrostat 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743411 | baxdrostat 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743411 | baxdrostat 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743412 | baxdrostat 2 MG [Baxfendy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743413 | BAXFENDY 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743413 | BAXFENDY 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743413 | BAXFENDY 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 274342 | Etopophos | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743526 | menthol 13 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743526 | menthol 13 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743526 | menthol 13 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743603 | Bulevirtide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2743603 | Bulevirtide | Designated preferred name (PT) | YES | |
| RxCUI: 2743603 | Bulevirtide | Full form of descriptor (FN) | YES | |
| RxCUI: 2743603 | Bulevirtide | Designated preferred name (PT) | YES | |
| RxCUI: 2743603 | Bulevirtide | Full form of descriptor (FN) | YES | |
| RxCUI: 2743604 | Bulevirtide acetate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2743604 | Bulevirtide acetate | Designated preferred name (PT) | YES | |
| RxCUI: 2743604 | Bulevirtide acetate | Full form of descriptor (FN) | YES | |
| RxCUI: 2743605 | bulevirtide-gmod | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2743606 | bulevirtide-gmod 8.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2743607 | bulevirtide Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2743608 | bulevirtide Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2743611 | bulevirtide-gmod 8.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743611 | bulevirtide-gmod 8.5 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2743612 | Hepcludex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743613 | bulevirtide-gmod 8.5 MG [Hepcludex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743614 | Hepcludex Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743615 | bulevirtide Injection [Hepcludex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743617 | HEPCLUDEX 8.5 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743617 | HEPCLUDEX 8.5 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743617 | HEPCLUDEX 8.5 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743618 | Differin Epiduo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2743619 | adapalene 0.001 MG/MG / benzoyl peroxide 0.025 MG/MG [Differin Epiduo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2743620 | Differin Epiduo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2743621 | adapalene / benzoyl peroxide Topical Gel [Differin Epiduo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2743622 | DIFFERIN EPIDUO 0.1 % / 2.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2743622 | DIFFERIN EPIDUO 0.1 % / 2.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2743622 | DIFFERIN EPIDUO 0.1 % / 2.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2743624 | dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG per 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743624 | dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG per 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743624 | dextromethorphan HBr 10 MG / doxylamine succinate 6.25 MG per 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2743625 | 1 daytime (dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG in 15 mL) / 1 nighttime (dextromethorphan hydrobromide 10 MG/ML / doxylamine succinate 6.25 MG in 15 mL) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2743625 | 1 daytime (dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG in 15 mL) / 1 nighttime (dextromethorphan hydrobromide 10 MG/ML / doxylamine succinate 6.25 MG in 15 mL) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2743625 | 1 daytime (dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG in 15 mL) / 1 nighttime (dextromethorphan hydrobromide 10 MG/ML / doxylamine succinate 6.25 MG in 15 mL) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743625 | 1 daytime (dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG in 15 mL) / 1 nighttime (dextromethorphan hydrobromide 10 MG/ML / doxylamine succinate 6.25 MG in 15 mL) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743625 | 1 daytime (dextromethorphan hydrobromide 10 MG / guaiFENesin 100 MG in 15 mL) / 1 nighttime (dextromethorphan hydrobromide 10 MG/ML / doxylamine succinate 6.25 MG in 15 mL) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2743713 | miconazole / undecylenate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2743714 | miconazole / undecylenate Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2743715 | miconazole / undecylenate Topical Spray | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2743718 | miconazole nitrate 2 % / undecylenic acid 25 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2743718 | miconazole nitrate 2 % / undecylenic acid 25 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2743718 | miconazole nitrate 2 % / undecylenic acid 25 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 27438 | imidazole salicylate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 27438 | imidazole salicylate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Designated preferred name (PT) | YES | |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Full form of descriptor (FN) | YES | |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Designated preferred name (PT) | YES | |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Full form of descriptor (FN) | YES | |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 274403 | Recombinant human insulin-like growth factor 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744162 | magnesium citrate 100 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744162 | magnesium citrate 100 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744163 | lutein 10 MG / zeaxanthin 2 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744163 | lutein 10 MG / zeaxanthin 2 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744280 | Dinoprostone 800 microgram/mL vaginal gel | Designated preferred name (PT) | NO | |
| RxCUI: 2744280 | Dinoprostone 800 microgram/mL vaginal gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2744281 | selexipag 0.1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744282 | selexipag 100 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744282 | selexipag 100 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744282 | selexipag 100 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744283 | selexipag 0.1 MG [Uptravi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744284 | Uptravi 100 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744284 | Uptravi 100 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744284 | Uptravi 100 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744284 | Uptravi 100 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744285 | selexipag 0.15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744286 | selexipag 150 MCG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744286 | selexipag 150 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744286 | selexipag 150 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744287 | selexipag 0.15 MG [Uptravi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744288 | Uptravi 150 MCG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744288 | Uptravi 150 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744288 | Uptravi 150 MCG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744288 | Uptravi 150 MCG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744289 | buspirone hydrochloride 2.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744289 | buspirone hydrochloride 2.5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744290 | busPIRone hydrochloride 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744290 | busPIRone hydrochloride 2.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744290 | busPIRone hydrochloride 2.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744291 | buspirone hydrochloride 12.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744291 | buspirone hydrochloride 12.5 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744292 | busPIRone hydrochloride 12.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744292 | busPIRone hydrochloride 12.5 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744292 | busPIRone hydrochloride 12.5 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744293 | hexylresorcinol 2 MG / menthol 6.1 MG Oral Lozeng | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744293 | hexylresorcinol 2 MG / menthol 6.1 MG Oral Lozeng | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744296 | pivekimab sunirine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2744297 | pivekimab sunirine-pvzy | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2744298 | pivekimab sunirine-pvzy 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744299 | pivekimab sunirine Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 27443 | Imidazoleglycerol-phosphate dehydratase | Designated preferred name (PT) | NO | |
| RxCUI: 27443 | Imidazoleglycerol-phosphate dehydratase | Full form of descriptor (FN) | NO | |
| RxCUI: 2744300 | pivekimab sunirine Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2744303 | pivekimab sunirine-pvzy 2 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744303 | pivekimab sunirine-pvzy 2 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744304 | Decnupaz | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2744305 | pivekimab sunirine-pvzy 2 MG [Decnupaz] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744306 | Decnupaz Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2744307 | pivekimab sunirine Injection [Decnupaz] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2744309 | Decnupaz 2 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744309 | Decnupaz 2 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744309 | Decnupaz 2 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744310 | acetaminophen / chlorpheniramine / dextromethorphan Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2744312 | acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744312 | acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744312 | acetaminophen 250 MG / chlorpheniramine maleate 2 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744313 | acetaminophen / dextromethorphan Effervescent Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2744315 | acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744315 | acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744315 | acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744316 | acetaminophen 1000 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 30 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744316 | acetaminophen 1000 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 30 mL Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744316 | acetaminophen 1000 MG / dextromethorphan HBr 30 MG / doxylamine succinate 12.5 MG in 30 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744447 | Dexlyt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2744448 | dexamethasone 0.25 MG [Dexlyt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744448 | dexamethasone 0.25 MG [Dexlyt] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744449 | Dexlyt Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2744450 | Dexlyt Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2744451 | dexamethasone Oral Tablet [Dexlyt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2744451 | dexamethasone Oral Tablet [Dexlyt] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744452 | Dexlyt 0.25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744452 | Dexlyt 0.25 MG Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744452 | Dexlyt 0.25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744452 | Dexlyt 0.25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744499 | naproxen sodium 110 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744500 | dextromethorphan / guaifenesin / naproxen Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2744500 | dextromethorphan / guaifenesin / naproxen Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744501 | dextromethorphan / guaifenesin / naproxen Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2744501 | dextromethorphan / guaifenesin / naproxen Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744502 | dextromethorphan / guaifenesin / naproxen Extended Release Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2744502 | dextromethorphan / guaifenesin / naproxen Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744503 | dextromethorphan hydrobromide / guaifenesin / naproxen sodium Oral Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744504 | dextromethorphan hydrobromide / guaifenesin / naproxen sodium Pill | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744505 | dextromethorphan hydrobromide / guaifenesin / naproxen sodium Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744506 | dextromethorphan hydrobromide 30 MG / guaiFENesin 600 MG / naproxen sodium 110 MG 12HR Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744506 | dextromethorphan hydrobromide 30 MG / guaiFENesin 600 MG / naproxen sodium 110 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744506 | dextromethorphan hydrobromide 30 MG / guaiFENesin 600 MG / naproxen sodium 110 MG 12HR Extended Release Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744506 | dextromethorphan hydrobromide 30 MG / guaiFENesin 600 MG / naproxen sodium 110 MG 12HR Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744506 | dextromethorphan hydrobromide 30 MG / guaiFENesin 600 MG / naproxen sodium 110 MG 12HR Extended Release Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744507 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / naproxen sodium 110 MG Extended Release Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744507 | dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG / naproxen sodium 110 MG Extended Release Oral Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2744508 | 1 daytime (acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine HCl 2 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet) | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2744508 | 1 daytime (acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine HCl 2 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744508 | 1 daytime (acetaminophen 250 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet) / 1 nighttime (acetaminophen 325 MG / chlorpheniramine HCl 2 MG / dextromethorphan HBr 10 MG Effervescent Oral Tablet) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744509 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG in 10 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2744509 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG in 10 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744509 | 1 daytime (acetaminophen 325 MG / dextromethorphan HBr 10 MG in 10 mL Oral Solution) / 1 nighttime (acetaminophen 325 MG / dextromethorphan HBr 10 MG / triprolidine HCl 1.25 MG in 10 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744510 | carboxymethylcellulose sodium 3 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2744511 | carboxymethylcellulose sodium 0.3 % / glycerin 1 % Ophthalmic Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744511 | carboxymethylcellulose sodium 0.3 % / glycerin 1 % Ophthalmic Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744511 | carboxymethylcellulose sodium 0.3 % / glycerin 1 % Ophthalmic Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744512 | buPROPion hydrochloride and dextromethorphan hydrobromide sample titration pack 105 MG/30 MG (21), 105 MG/45 MG (14) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2744512 | buPROPion hydrochloride and dextromethorphan hydrobromide sample titration pack 105 MG/30 MG (21), 105 MG/45 MG (14) Oral Tablet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744512 | buPROPion hydrochloride and dextromethorphan hydrobromide sample titration pack 105 MG/30 MG (21), 105 MG/45 MG (14) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744512 | buPROPion hydrochloride and dextromethorphan hydrobromide sample titration pack 105 MG/30 MG (21), 105 MG/45 MG (14) Oral Tablet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744512 | buPROPion hydrochloride and dextromethorphan hydrobromide sample titration pack 105 MG/30 MG (21), 105 MG/45 MG (14) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744513 | Auvelity Sample Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2744513 | Auvelity Sample Titration Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744513 | Auvelity Sample Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744513 | Auvelity Sample Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744514 | buPROPion hydrochloride and dextromethorphan hydrobromide titration pack 105 MG/30 MG (21), 105 MG/45 MG (30) Oral Tablet Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2744514 | buPROPion hydrochloride and dextromethorphan hydrobromide titration pack 105 MG/30 MG (21), 105 MG/45 MG (30) Oral Tablet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744514 | buPROPion hydrochloride and dextromethorphan hydrobromide titration pack 105 MG/30 MG (21), 105 MG/45 MG (30) Oral Tablet Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744514 | buPROPion hydrochloride and dextromethorphan hydrobromide titration pack 105 MG/30 MG (21), 105 MG/45 MG (30) Oral Tablet Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744514 | buPROPion hydrochloride and dextromethorphan hydrobromide titration pack 105 MG/30 MG (21), 105 MG/45 MG (30) Oral Tablet Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744515 | Auvelity Titration Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2744515 | Auvelity Titration Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744515 | Auvelity Titration Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744515 | Auvelity Titration Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744608 | benzalkonium chloride 0.13 % / lidocaine 4 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744608 | benzalkonium chloride 0.13 % / lidocaine 4 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744608 | benzalkonium chloride 0.13 % / lidocaine 4 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744628 | menthol 76.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2744629 | menthol 7.66 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744629 | menthol 7.66 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744629 | menthol 7.66 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744630 | miconazole nitrate 20 MG/ML [Lasolex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744631 | miconazole Topical Cream [Lasolex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2744633 | Lasolex AC 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744633 | Lasolex AC 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744633 | Lasolex AC 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744718 | Desflurane 990 mg/mL solution for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2744718 | Desflurane 990 mg/mL solution for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2744719 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Designated preferred name (PT) | NO | |
| RxCUI: 2744719 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744719 | Flucloxacillin (as flucloxacillin magnesium) 25 mg/mL oral suspension | Full form of descriptor (FN) | NO | |
| RxCUI: 2744720 | Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2744720 | Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2744720 | Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2744720 | Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2744720 | Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2744720 | Product containing precisely quinine dihydrochloride 300 milligram/1 milliliter conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2744721 | Ibuprofen 600 mg granules for oral suspension sachet | Designated preferred name (PT) | NO | |
| RxCUI: 2744721 | Ibuprofen 600 mg granules for oral suspension sachet | Full form of descriptor (FN) | NO | |
| RxCUI: 2744725 | menthol 4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744725 | menthol 4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744725 | menthol 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744727 | Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment | Designated preferred name (PT) | NO | |
| RxCUI: 2744727 | Heparinoid 2 mg/g and lauromacrogol 400 50 mg/g rectal ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 2744728 | Isosorbide dinitrate 30 mg/actuation transdermal spray | Designated preferred name (PT) | NO | |
| RxCUI: 2744728 | Isosorbide dinitrate 30 mg/actuation transdermal spray | Full form of descriptor (FN) | NO | |
| RxCUI: 2744729 | Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2744729 | Product containing precisely selenium sulfide 25 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2744730 | Nicotine (as nicotine bitartrate) 1 mg oromucosal lozenge | Designated preferred name (PT) | NO | |
| RxCUI: 2744730 | Nicotine (as nicotine bitartrate) 1 mg oromucosal lozenge | Full form of descriptor (FN) | NO | |
| RxCUI: 2744791 | Strideguard Dewormer | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2744792 | fenbendazole 0.1 MG/MG [Strideguard Dewormer] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2744793 | Strideguard Dewormer Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2744794 | Strideguard Dewormer Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2744795 | Strideguard Dewormer Oral Paste Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2744796 | fenbendazole Oral Paste [Strideguard Dewormer] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2744797 | StrideGuard Equine Dewormer 10 % Oral Paste | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744797 | StrideGuard Equine Dewormer 10 % Oral Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744797 | StrideGuard Equine Dewormer 10 % Oral Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744799 | Canibendan | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2744800 | pimobendan 1.25 MG [Canibendan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2744801 | Canibendan Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2744802 | Canibendan Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2744803 | Canibendan Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2744804 | pimobendan Chewable Tablet [Canibendan] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2744805 | CaniBendan 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744805 | CaniBendan 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744805 | CaniBendan 1.25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744806 | pimobendan 10 MG [Canibendan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2744807 | CaniBendan 10 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744807 | CaniBendan 10 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744807 | CaniBendan 10 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744808 | pimobendan 2.5 MG [Canibendan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2744809 | CaniBendan 2.5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744809 | CaniBendan 2.5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744809 | CaniBendan 2.5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744810 | pimobendan 5 MG [Canibendan] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2744811 | CaniBendan 5 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744811 | CaniBendan 5 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744811 | CaniBendan 5 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744813 | zidebactam | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2744814 | zidebactam dihydrate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2744815 | zidebactam 1000 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744816 | cefepime / zidebactam | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2744817 | cefepime / zidebactam Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2744818 | cefepime / zidebactam Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2744819 | cefepime 2 GM / zidebactam 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744819 | cefepime 2 GM / zidebactam 1 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744819 | cefepime 2 GM / zidebactam 1 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744819 | cefepime 2 GM / zidebactam 1 GM Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744820 | Zaynich | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2744821 | cefepime 2000 MG / zidebactam 1000 MG [Zaynich] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744822 | Zaynich Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2744823 | cefepime / zidebactam Injection [Zaynich] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2744824 | ZAYNICH 3 GM Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744824 | ZAYNICH 3 GM Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744824 | ZAYNICH 3 GM Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744825 | lidocaine / phenylephrine Medicated Pad or Tape | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2744826 | lidocaine / phenylephrine Medicated Pad | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2744830 | lidocaine 5 % / phenylephrine HCl 0.25 % Medicated Pad | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744830 | lidocaine 5 % / phenylephrine HCl 0.25 % Medicated Pad | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744830 | lidocaine 5 % / phenylephrine HCl 0.25 % Medicated Pad | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744883 | ranibizumab-leyk | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2744884 | ranibizumab-leyk 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744887 | ranibizumab-leyk 0.5 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744887 | ranibizumab-leyk 0.5 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744887 | ranibizumab-leyk 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744887 | ranibizumab-leyk 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744888 | ranibizumab-leyk 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744889 | Nufymco | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2744890 | ranibizumab-leyk 10 MG/ML [Nufymco] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744891 | Nufymco Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2744892 | ranibizumab Injection [Nufymco] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2744894 | Nufymco 0.5 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744894 | Nufymco 0.5 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744894 | Nufymco 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744894 | Nufymco 0.5 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744895 | ranibizumab-leyk 10 MG/ML Injection [Nufymco] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744895 | ranibizumab-leyk 10 MG/ML Injection [Nufymco] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744896 | ranibizumab-leyk 6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2744897 | ranibizumab-leyk 0.3 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2744897 | ranibizumab-leyk 0.3 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744897 | ranibizumab-leyk 0.3 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744897 | ranibizumab-leyk 0.3 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744898 | ranibizumab-leyk 6 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744899 | ranibizumab-leyk 6 MG/ML [Nufymco] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2744900 | Nufymco 0.3 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2744900 | Nufymco 0.3 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744900 | Nufymco 0.3 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744900 | Nufymco 0.3 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744901 | ranibizumab-leyk 6 MG/ML Injection [Nufymco] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744901 | ranibizumab-leyk 6 MG/ML Injection [Nufymco] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744976 | meloxicam 0.5 MG/ML [Ostilox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2744977 | OstiLox 0.5 MG in 1 mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2744977 | OstiLox 0.5 MG in 1 mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744977 | OstiLox 0.5 MG in 1 mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744978 | menthol 0.03 MG/MG / methyl salicylate 0.01 MG/MG Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2744978 | menthol 0.03 MG/MG / methyl salicylate 0.01 MG/MG Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2744978 | menthol 0.03 MG/MG / methyl salicylate 0.01 MG/MG Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2744979 | 1 daytime (acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG / pseudoephedrine HCl 30 MG Oral Tablet) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2744979 | 1 daytime (acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG / pseudoephedrine HCl 30 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744979 | 1 daytime (acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG / pseudoephedrine HCl 30 MG Oral Tablet) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2744979 | 1 daytime (acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG / pseudoephedrine HCl 30 MG Oral Tablet) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2744979 | 1 daytime (acetaminophen 500 MG / pseudoephedrine HCl 30 MG Oral Tablet) / 1 nighttime (acetaminophen 500 MG / diphenhydrAMINE HCl 25 MG / pseudoephedrine HCl 30 MG Oral Tablet) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2744980 | Methotrexate 10 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2744980 | Methotrexate 10 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2744981 | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2744981 | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2744982 | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2744982 | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2744983 | Betamethasone (as betamethasone valerate) 250 microgram/g cutaneous ointment | Designated preferred name (PT) | NO | |
| RxCUI: 2744983 | Betamethasone (as betamethasone valerate) 250 microgram/g cutaneous ointment | Full form of descriptor (FN) | NO | |
| RxCUI: 2745120 | gadoquatrane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2745120 | gadoquatrane | Designated preferred name (PT) | YES | |
| RxCUI: 2745120 | gadoquatrane | Full form of descriptor (FN) | YES | |
| RxCUI: 2745120 | gadoquatrane | Designated preferred name (PT) | YES | |
| RxCUI: 2745120 | gadoquatrane | Full form of descriptor (FN) | YES | |
| RxCUI: 2745122 | Yulithira | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745123 | everolimus 10 MG [Yulithira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745124 | Yulithira Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745125 | Yulithira Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745126 | everolimus Oral Tablet [Yulithira] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745127 | Yulithira 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745127 | Yulithira 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745127 | Yulithira 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745128 | everolimus 2.5 MG [Yulithira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745129 | Yulithira 2.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745129 | Yulithira 2.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745129 | Yulithira 2.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745130 | everolimus 5 MG [Yulithira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745131 | Yulithira 5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745131 | Yulithira 5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745131 | Yulithira 5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745132 | everolimus 7.5 MG [Yulithira] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745133 | Yulithira 7.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745133 | Yulithira 7.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745133 | Yulithira 7.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745134 | Cligavyx | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745135 | fulvestrant 50 MG/ML [Cligavyx] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745136 | Cligavyx Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745137 | fulvestrant Prefilled Syringe [Cligavyx] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745138 | CLIGAVYX 250 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745138 | CLIGAVYX 250 MG in 5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745138 | CLIGAVYX 250 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745138 | CLIGAVYX 250 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745139 | fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745139 | fulvestrant 50 MG/ML Prefilled Syringe [Cligavyx] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745140 | linerixibat 40 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745141 | linerixibat Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745142 | linerixibat Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745143 | linerixibat Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2745144 | linerixibat 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745144 | linerixibat 40 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745145 | Lynavoy | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745146 | linerixibat 40 MG [Lynavoy] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745147 | Lynavoy Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745148 | Lynavoy Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745149 | linerixibat Oral Tablet [Lynavoy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745150 | Lynavoy 40 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745150 | Lynavoy 40 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745150 | Lynavoy 40 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745151 | Trilitas | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745152 | tazarotene 0.001 MG/MG [Trilitas] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745153 | Trilitas Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745154 | tazarotene Topical Gel [Trilitas] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745155 | Trilitas 0.1 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745155 | Trilitas 0.1 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745155 | Trilitas 0.1 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745185 | marstacimab-hncq 75 MG in 0.5 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745185 | marstacimab-hncq 75 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745185 | marstacimab-hncq 75 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745186 | HYMPAVZI 75 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745186 | HYMPAVZI 75 MG in 0.5 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745186 | HYMPAVZI 75 MG in 0.5 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745186 | HYMPAVZI 75 MG in 0.5 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745187 | marstacimab-hncq 75 MG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745187 | marstacimab-hncq 75 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745187 | marstacimab-hncq 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745188 | HYMPAVZI 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745188 | HYMPAVZI 75 MG in 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745188 | HYMPAVZI 75 MG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745188 | HYMPAVZI 75 MG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745297 | zinc oxide 8 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745297 | zinc oxide 8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745297 | zinc oxide 8 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745297 | zinc oxide 8 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745298 | Ursolign | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745299 | ursodiol 150 MG [Ursolign] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745300 | Ursolign Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745301 | Ursolign Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745302 | ursodeoxycholate Oral Capsule [Ursolign] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745304 | URSOLIGN 150 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745304 | URSOLIGN 150 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745304 | URSOLIGN 150 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745305 | camphor / lidocaine / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2745306 | camphor / lidocaine / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745307 | camphor / lidocaine / menthol Medicated Patch | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2745308 | camphor 0.2 % / lidocaine 4 % / menthol 0.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745308 | camphor 0.2 % / lidocaine 4 % / menthol 0.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745308 | camphor 0.2 % / lidocaine 4 % / menthol 0.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 274534 | Inolimomab | Designated preferred name (PT) | NO | |
| RxCUI: 274534 | Inolimomab | Full form of descriptor (FN) | NO | |
| RxCUI: 274535 | Spiriva | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745399 | chlorhexidine gluconate 0.001 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2745400 | chlorhexidine / zinc oxide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2745401 | chlorhexidine / zinc oxide Paste Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2745402 | chlorhexidine / zinc oxide Paste | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2745405 | zinc oxide 30 % / chlorhexidine gluconate 0.1 % Paste | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745405 | zinc oxide 30 % / chlorhexidine gluconate 0.1 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745405 | zinc oxide 30 % / chlorhexidine gluconate 0.1 % Paste | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745405 | zinc oxide 30 % / chlorhexidine gluconate 0.1 % Paste | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745406 | ketoconazole N-oxide | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 2745407 | deflazacort 22.75 MG/ML [Kymbee] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745408 | Kymbee Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745409 | deflazacort Oral Suspension [Kymbee] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745410 | KYMBEE 22.75 MG/mL Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745410 | KYMBEE 22.75 MG/mL Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745410 | KYMBEE 22.75 MG/mL Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745411 | risankizumab-rzaa 149 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745412 | risankizumab-rzaa 55 MG in 0.37 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745412 | risankizumab-rzaa 55 MG in 0.37 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745412 | risankizumab-rzaa 55 MG in 0.37 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745413 | risankizumab-rzaa 149 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745413 | risankizumab-rzaa 149 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745413 | risankizumab-rzaa 149 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745414 | risankizumab-rzaa 149 MG/ML [Skyrizi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745415 | Skyrizi 55 MG in 0.37 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745415 | Skyrizi 55 MG in 0.37 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745415 | Skyrizi 55 MG in 0.37 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745416 | Skyrizi 149 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745416 | Skyrizi 149 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745416 | Skyrizi 149 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745448 | emodin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2745576 | propoxur | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2745579 | menthol / pramoxine Topical Ointment | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2745581 | menthol 0.1 % / pramoxine hydrochloride 1 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745581 | menthol 0.1 % / pramoxine hydrochloride 1 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745581 | menthol 0.1 % / pramoxine hydrochloride 1 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745582 | Coumafos | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745582 | Coumafos | Full form of descriptor (FN) | NO | |
| RxCUI: 2745582 | Coumafos | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2745582 | Coumafos | Designated preferred name (PT) | NO | |
| RxCUI: 2745583 | coumaphos 0.03 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2745584 | propoxur 0.02 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2745585 | sulfanilamide 0.05 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2745586 | coumaphos / propoxur / sulfanilamide | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2745587 | coumaphos / propoxur / sulfanilamide Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2745588 | coumaphos / propoxur / sulfanilamide Topical Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2745589 | coumaphos 3 % / propoxur 2 % / sulfanilamide 5 % Topical Powder (EUA) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745589 | coumaphos 3 % / propoxur 2 % / sulfanilamide 5 % Topical Powder (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745589 | coumaphos 3 % / propoxur 2 % / sulfanilamide 5 % Topical Powder (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745590 | Negasunt | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2745591 | coumaphos 0.03 MG/MG / propoxur 0.02 MG/MG / sulfanilamide 0.05 MG/MG [Negasunt] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2745592 | Negasunt Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2745593 | coumaphos / propoxur / sulfanilamide Topical Powder [Negasunt] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2745594 | Negasunt Powder 3 % / 2 % / 5 % Topical Powder (EUA) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745594 | Negasunt Powder 3 % / 2 % / 5 % Topical Powder (EUA) | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745594 | Negasunt Powder 3 % / 2 % / 5 % Topical Powder (EUA) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745595 | cholecalciferol Oral Film Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745596 | cholecalciferol Oral Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2745597 | cholecalciferol 50 MCG (2000 UNT) Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745597 | cholecalciferol 50 MCG (2000 UNT) Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745597 | cholecalciferol 50 MCG (2000 UNT) Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745598 | vitamin B12 Oral Film Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745599 | vitamin B12 Oral Film | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2745600 | vitamin B 12 500 MCG Oral Film | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745600 | vitamin B 12 500 MCG Oral Film | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745600 | vitamin B 12 500 MCG Oral Film | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745753 | trabectedin 0.05 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745754 | trabectedin 1 MG in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745754 | trabectedin 1 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745754 | trabectedin 1 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745754 | trabectedin 1 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745755 | trabectedin 0.05 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745756 | Evdi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745757 | trabectedin 0.05 MG/ML [Evdi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745758 | Evdi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745759 | trabectedin Injection [Evdi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745760 | EVDI 1 MG in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745760 | EVDI 1 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745760 | EVDI 1 MG in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745760 | EVDI 1 MG in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745761 | trabectedin 0.05 MG/ML Injection [Evdi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745761 | trabectedin 0.05 MG/ML Injection [Evdi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745765 | milsaperidone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2745766 | milsaperidone 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745767 | milsaperidone Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745768 | milsaperidone Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745769 | milsaperidone Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2745770 | milsaperidone 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745770 | milsaperidone 1 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745771 | Bysanti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745772 | milsaperidone 1 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745773 | Bysanti Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745774 | Bysanti Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745775 | milsaperidone Oral Tablet [Bysanti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745776 | Bysanti 1 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745776 | Bysanti 1 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745776 | Bysanti 1 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745777 | milsaperidone 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745778 | milsaperidone 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745778 | milsaperidone 10 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745779 | milsaperidone 10 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745780 | Bysanti 10 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745780 | Bysanti 10 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745780 | Bysanti 10 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745781 | milsaperidone 12 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745782 | milsaperidone 12 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745782 | milsaperidone 12 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745783 | milsaperidone 12 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745784 | Bysanti 12 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745784 | Bysanti 12 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745784 | Bysanti 12 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745785 | milsaperidone 2 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745786 | milsaperidone 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745786 | milsaperidone 2 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745787 | milsaperidone 2 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745788 | Bysanti 2 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745788 | Bysanti 2 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745788 | Bysanti 2 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745789 | milsaperidone 4 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745790 | milsaperidone 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745790 | milsaperidone 4 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745791 | milsaperidone 4 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745792 | Bysanti 4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745792 | Bysanti 4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745792 | Bysanti 4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745793 | milsaperidone 6 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745794 | milsaperidone 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745794 | milsaperidone 6 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745795 | milsaperidone 6 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745796 | Bysanti 6 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745796 | Bysanti 6 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745796 | Bysanti 6 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745797 | milsaperidone 8 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745798 | milsaperidone 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745798 | milsaperidone 8 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745799 | milsaperidone 8 MG [Bysanti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745800 | Bysanti 8 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745800 | Bysanti 8 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745800 | Bysanti 8 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745801 | semaglutide 9.6 MG in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745801 | semaglutide 9.6 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745801 | semaglutide 9.6 MG in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745801 | semaglutide 9.6 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745802 | semaglutide 3.2 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745803 | semaglutide Pen Injector [Wegovy] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745804 | wegovy FlexTouch 9.6 MG in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745804 | wegovy FlexTouch 9.6 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745804 | wegovy FlexTouch 9.6 MG in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745804 | wegovy FlexTouch 9.6 MG in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745805 | semaglutide 3.2 MG/ML Pen Injector [Wegovy] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745805 | semaglutide 3.2 MG/ML Pen Injector [Wegovy] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745864 | duloxetine 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745864 | duloxetine 80 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745865 | DULoxetine 80 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745865 | DULoxetine 80 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745865 | DULoxetine 80 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745865 | DULoxetine 80 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745865 | DULoxetine 80 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745866 | duloxetine 90 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745866 | duloxetine 90 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745867 | DULoxetine 90 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745867 | DULoxetine 90 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745867 | DULoxetine 90 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745867 | DULoxetine 90 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745867 | DULoxetine 90 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745868 | duloxetine 120 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745868 | duloxetine 120 MG | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745869 | DULoxetine 120 MG Delayed Release Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745869 | DULoxetine 120 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745869 | DULoxetine 120 MG Delayed Release Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745869 | DULoxetine 120 MG Delayed Release Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745869 | DULoxetine 120 MG Delayed Release Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2745870 | Navitrux | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745871 | fosaprepitant 150 MG [Navitrux] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745872 | Navitrux Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745873 | fosaprepitant Injection [Navitrux] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745874 | NAVITRUX 150 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745874 | NAVITRUX 150 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745874 | NAVITRUX 150 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745874 | NAVITRUX 150 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2745888 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2745888 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2745888 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745888 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745888 | 1 daytime (dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 20 mL Oral Solution) / 1 nighttime (dextromethorphan HBr 20 MG / triprolidine HCl 2.5 MG in 20 mL Oral Solution) Pack | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2745969 | doxylamine succinate 6.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745969 | doxylamine succinate 6.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745970 | camphor 3 % / menthol 3.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2745970 | camphor 3 % / menthol 3.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745970 | camphor 3 % / menthol 3.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745971 | camphor 0.03 MG/MG / menthol 0.035 MG/MG [Ortho-Nesic] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2745972 | Ortho-Nesic 3 % / 3.5 % Topical Gel | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745972 | Ortho-Nesic 3 % / 3.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745972 | Ortho-Nesic 3 % / 3.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745973 | Terpenicol | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2745974 | undecylenic acid 250 MG/ML [Terpenicol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2745975 | Terpenicol Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2745976 | undecylenate Topical Solution [Terpenicol] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2745978 | TERPENICOL 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745978 | TERPENICOL 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745978 | TERPENICOL 25 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745979 | Terpenicol Antifungal | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2745980 | miconazole nitrate 20 MG/ML [Terpenicol Antifungal] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2745981 | Terpenicol Antifungal Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2745982 | miconazole Topical Cream [Terpenicol Antifungal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2745984 | TERPENICOL ANTIFUNGAL 2 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745984 | TERPENICOL ANTIFUNGAL 2 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745984 | TERPENICOL ANTIFUNGAL 2 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745985 | miconazole Topical Solution [Terpenicol Antifungal] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2745987 | TERPENICOL ANTIFUNGAL 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2745987 | TERPENICOL ANTIFUNGAL 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2745987 | TERPENICOL ANTIFUNGAL 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2745988 | ensitrelvir | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2745989 | ensitrelvir 125 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2745990 | ensitrelvir Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745991 | ensitrelvir Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2745992 | ensitrelvir Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2745993 | ensitrelvir 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745993 | ensitrelvir 125 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2745994 | Xocova | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2745995 | ensitrelvir 125 MG [Xocova] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2745996 | Xocova Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745997 | Xocova Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2745998 | ensitrelvir Oral Tablet [Xocova] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2745999 | XOCOVA 125 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2745999 | XOCOVA 125 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2745999 | XOCOVA 125 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746000 | ensitrelvir 125 MG Oral Tablet (7) 5-Day Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2746000 | ensitrelvir 125 MG Oral Tablet (7) 5-Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746000 | ensitrelvir 125 MG Oral Tablet (7) 5-Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746001 | XOCOVA 5-Day Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2746001 | XOCOVA 5-Day Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746001 | XOCOVA 5-Day Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746002 | veligrotug | Full form of descriptor (FN) | YES | |
| RxCUI: 2746002 | veligrotug | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2746002 | veligrotug | Designated preferred name (PT) | YES | |
| RxCUI: 2746002 | veligrotug | Full form of descriptor (FN) | YES | |
| RxCUI: 2746002 | veligrotug | Designated preferred name (PT) | YES | |
| RxCUI: 2746003 | veligrotug-vvze | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746004 | veligrotug-vvze 50 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746005 | veligrotug Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2746006 | veligrotug Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2746009 | veligrotug-vvze 500 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746009 | veligrotug-vvze 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746009 | veligrotug-vvze 500 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746009 | veligrotug-vvze 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746010 | veligrotug-vvze 50 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746011 | Lumvoa | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746012 | veligrotug-vvze 50 MG/ML [Lumvoa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746013 | Lumvoa Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746014 | veligrotug Injection [Lumvoa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746016 | LUMVOA 500 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746016 | LUMVOA 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746016 | LUMVOA 500 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746016 | LUMVOA 500 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746017 | veligrotug-vvze 50 MG/ML Injection [Lumvoa] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746017 | veligrotug-vvze 50 MG/ML Injection [Lumvoa] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746018 | milsaperidone 1 MG (2), 2 MG (2), 4 MG (2), 6 MG (2) Oral Tablet, Titration Pack A | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2746018 | milsaperidone 1 MG (2), 2 MG (2), 4 MG (2), 6 MG (2) Oral Tablet, Titration Pack A | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746018 | milsaperidone 1 MG (2), 2 MG (2), 4 MG (2), 6 MG (2) Oral Tablet, Titration Pack A | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746019 | BYSANTI TITRATION PACK A | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2746019 | BYSANTI TITRATION PACK A | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746019 | BYSANTI TITRATION PACK A | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746020 | milsaperidone 1 MG (6), 2 MG (2), 6 MG (2), 8 MG (2) Oral Tablet, Titration Pack B | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2746020 | milsaperidone 1 MG (6), 2 MG (2), 6 MG (2), 8 MG (2) Oral Tablet, Titration Pack B | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746020 | milsaperidone 1 MG (6), 2 MG (2), 6 MG (2), 8 MG (2) Oral Tablet, Titration Pack B | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746021 | Bysanti TITRATION PACK B | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2746021 | Bysanti TITRATION PACK B | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746021 | Bysanti TITRATION PACK B | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746022 | milsaperidone 1 MG (4), 2 MG (2), 6 MG (2) Oral Tablet, Titration Pack C | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2746022 | milsaperidone 1 MG (4), 2 MG (2), 6 MG (2) Oral Tablet, Titration Pack C | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746022 | milsaperidone 1 MG (4), 2 MG (2), 6 MG (2) Oral Tablet, Titration Pack C | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746023 | Bysanti TITRATION PACK C | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2746023 | Bysanti TITRATION PACK C | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746023 | Bysanti TITRATION PACK C | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746143 | ethanol 0.675 ML/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2746144 | ethanol 67.5 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746144 | ethanol 67.5 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746144 | ethanol 67.5 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746145 | influenza A virus A/Darwin/1415/2025 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746146 | influenza A virus A/Michigan/105/2025 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746147 | influenza A virus A/Tasmania/787/2025 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746148 | influenza A virus A/Missouri/11/2025 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746149 | influenza A virus A/Tasmania/318/2025 (H1N1) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746150 | influenza B virus B/Arizona/21/2025 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746151 | influenza B virus B/Pennsylvania/14/2025 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746152 | influenza B virus B/Tokyo/EIS13-175/2025 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 27463 | Immunoconglutinin | Designated preferred name (PT) | NO | |
| RxCUI: 27463 | Immunoconglutinin | Full form of descriptor (FN) | NO | |
| RxCUI: 2746437 | influenza A virus A/Darwin/1415/2025 (H3N2) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746438 | influenza A virus A/Missouri/11/2025 (H1N1) antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746439 | influenza B virus B/Pennsylvania/14/2025 antigen 0.09 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746442 | influenza virus vaccine 2026-2027 (trivalent - Darwin/Missouri/Pennsylvania) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746442 | influenza virus vaccine 2026-2027 (trivalent - Darwin/Missouri/Pennsylvania) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746442 | influenza virus vaccine 2026-2027 (trivalent - Darwin/Missouri/Pennsylvania) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746443 | influenza virus vaccine 2026-2027 (trivalent - Darwin/Missouri/Pennsylvania) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746443 | influenza virus vaccine 2026-2027 (trivalent - Darwin/Missouri/Pennsylvania) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746443 | influenza virus vaccine 2026-2027 (trivalent - Darwin/Missouri/Pennsylvania) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746444 | Flublok 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746445 | influenza A virus A/Darwin/1415/2025 (H3N2) antigen 0.09 MG/ML / influenza A virus A/Missouri/11/2025 (H1N1) antigen 0.09 MG/ML / influenza B virus B/Pennsylvania/14/2025 antigen 0.09 MG/ML [Flublok 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746446 | Flublok 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746447 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flublok 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746449 | Flublok 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746449 | Flublok 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746449 | Flublok 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746450 | Flublok 2026-2027 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746450 | Flublok 2026-2027 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746450 | Flublok 2026-2027 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746451 | acetaminophen 325 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746451 | acetaminophen 325 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746451 | acetaminophen 325 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746451 | acetaminophen 325 MG / doxylamine succinate 6.25 MG in 15 mL Oral Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746452 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746453 | influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746456 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Injectable Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746456 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746456 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746457 | Fluzone 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746458 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML [Fluzone 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746459 | Fluzone 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746460 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Injectable Suspension [Fluzone 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746462 | Fluzone 2026-2027 trivalent vaccine Injectable Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746462 | Fluzone 2026-2027 trivalent vaccine Injectable Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746462 | Fluzone 2026-2027 trivalent vaccine Injectable Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746464 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746464 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746464 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746465 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746465 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746465 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746466 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluzone 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746468 | Fluzone 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746468 | Fluzone 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746468 | Fluzone 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746469 | Fluzone 2026-2027 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746469 | Fluzone 2026-2027 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746469 | Fluzone 2026-2027 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746470 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746471 | influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.12 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746472 | influenza virus high-dose vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746472 | influenza virus high-dose vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746472 | influenza virus high-dose vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746473 | influenza virus high-dose vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746473 | influenza virus high-dose vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746473 | influenza virus high-dose vaccine 2026-2027 (trivalent - Michigan/Switzerland/Tokyo) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746474 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.12 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.12 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.12 MG/ML [Fluzone 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746475 | Fluzone 2026-2027 high-dose vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746475 | Fluzone 2026-2027 high-dose vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746475 | Fluzone 2026-2027 high-dose vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746476 | Fluzone 2026-2027 high-dose vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746476 | Fluzone 2026-2027 high-dose vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746476 | Fluzone 2026-2027 high-dose vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746477 | influenza A virus A/Tasmania/787/2025 (H3N2) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746478 | influenza A virus A/Tasmania/318/2025 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746479 | influenza B virus B/Arizona/21/2025 antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746482 | influenza virus vaccine 2026-2027 (trivalent - Tasmania/Tasmania/Arizona) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746482 | influenza virus vaccine 2026-2027 (trivalent - Tasmania/Tasmania/Arizona) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746482 | influenza virus vaccine 2026-2027 (trivalent - Tasmania/Tasmania/Arizona) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746483 | influenza virus vaccine 2026-2027 (trivalent - Tasmania/Tasmania/Arizona) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746483 | influenza virus vaccine 2026-2027 (trivalent - Tasmania/Tasmania/Arizona) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746483 | influenza virus vaccine 2026-2027 (trivalent - Tasmania/Tasmania/Arizona) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746484 | Flucelvax 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746485 | influenza A virus A/Tasmania/318/2025 (H1N1) antigen 0.03 MG/ML / influenza A virus A/Tasmania/787/2025 (H3N2) antigen 0.03 MG/ML / influenza B virus B/Arizona/21/2025 antigen 0.03 MG/ML [Flucelvax 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746486 | Flucelvax 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746487 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flucelvax 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746489 | Flucelvax 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746489 | Flucelvax 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746489 | Flucelvax 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746490 | Flucelvax 2026-2027 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746490 | Flucelvax 2026-2027 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746490 | Flucelvax 2026-2027 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746492 | azelaic acid 100 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2746493 | azelaic acid 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746493 | azelaic acid 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746493 | azelaic acid 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746494 | menthol 1.25 % / methyl salicylate 15 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746494 | menthol 1.25 % / methyl salicylate 15 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746494 | menthol 1.25 % / methyl salicylate 15 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746495 | olezarsen 62.5 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746496 | olezarsen 50 MG in 0.8 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746496 | olezarsen 50 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746496 | olezarsen 50 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746497 | olezarsen 62.5 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746497 | olezarsen 62.5 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746498 | olezarsen 62.5 MG/ML [Tryngolza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746499 | Tryngolza 50 MG in 0.8 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746499 | Tryngolza 50 MG in 0.8 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746499 | Tryngolza 50 MG in 0.8 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746500 | Tryngolza 62.5 MG/ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746500 | Tryngolza 62.5 MG/ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746500 | Tryngolza 62.5 MG/ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746501 | miconazole Topical Solution [Lasolex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746503 | Lasolex AL 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746503 | Lasolex AL 2 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746503 | Lasolex AL 2 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746503 | Lasolex AL 2 % Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746545 | axatilimab-csfr 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746546 | axatilimab-csfr 22 MG in 2.2 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746546 | axatilimab-csfr 22 MG in 2.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746546 | axatilimab-csfr 22 MG in 2.2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746546 | axatilimab-csfr 22 MG in 2.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746547 | axatilimab-csfr 10 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746548 | axatilimab-csfr 10 MG/ML [Niktimvo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746549 | Niktimvo 22 MG in 2.2 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746549 | Niktimvo 22 MG in 2.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746549 | Niktimvo 22 MG in 2.2 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746549 | Niktimvo 22 MG in 2.2 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746550 | axatilimab-csfr 10 MG/ML Injection [Niktimvo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746550 | axatilimab-csfr 10 MG/ML Injection [Niktimvo] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746551 | axatilimab-csfr 9 MG in 0.9 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746551 | axatilimab-csfr 9 MG in 0.9 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746551 | axatilimab-csfr 9 MG in 0.9 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746551 | axatilimab-csfr 9 MG in 0.9 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746552 | Niktimvo 9 MG in 0.9 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746552 | Niktimvo 9 MG in 0.9 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746552 | Niktimvo 9 MG in 0.9 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746552 | Niktimvo 9 MG in 0.9 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746554 | insulin glargine-aldy | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746560 | Langlara | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746562 | Langlara Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746563 | insulin glargine Pen Injector [Langlara] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746567 | insulin glargine-aldy 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746568 | insulin glargine-aldy 300 UNT in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746568 | insulin glargine-aldy 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746568 | insulin glargine-aldy 300 UNT in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746568 | insulin glargine-aldy 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746569 | insulin glargine-aldy 100 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746570 | insulin glargine-aldy 100 UNT/ML [Langlara] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746571 | Langlara (insulin glargine-aldy) 300 UNT in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746571 | Langlara (insulin glargine-aldy) 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746571 | Langlara (insulin glargine-aldy) 300 UNT in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746571 | Langlara (insulin glargine-aldy) 300 UNT in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746572 | insulin glargine-aldy 100 UNT/ML Pen Injector [Langlara] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746572 | insulin glargine-aldy 100 UNT/ML Pen Injector [Langlara] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746867 | denosumab-desu | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2746868 | denosumab-desu 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746871 | denosumab-desu 60 MG in 1 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746871 | denosumab-desu 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746871 | denosumab-desu 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746872 | denosumab-desu 60 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746873 | Osvyrti | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746874 | denosumab-desu 60 MG/ML [Osvyrti] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746875 | Osvyrti Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746876 | denosumab Prefilled Syringe [Osvyrti] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746878 | OSVYRTI 60 MG in 1 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746878 | OSVYRTI 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746878 | OSVYRTI 60 MG in 1 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746878 | OSVYRTI 60 MG in 1 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746879 | denosumab-desu 60 MG/ML Prefilled Syringe [Osvyrti] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746879 | denosumab-desu 60 MG/ML Prefilled Syringe [Osvyrti] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746880 | Nizoral Psoriasis Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746881 | salicylic acid Topical Cream [Nizoral Psoriasis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746882 | Nizoral Psoriasis 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746882 | Nizoral Psoriasis 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746882 | Nizoral Psoriasis 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746882 | Nizoral Psoriasis 3 % Topical Cream | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746883 | Tiocystin | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746884 | tiopronin 100 MG [Tiocystin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746885 | Tiocystin Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746886 | Tiocystin Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746887 | tiopronin Oral Tablet [Tiocystin] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746888 | Tiocystin 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746888 | Tiocystin 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746888 | Tiocystin 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746889 | tiopronin 200 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746890 | tiopronin 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746890 | tiopronin 200 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746891 | tiopronin 200 MG [Tiocystin] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746892 | Tiocystin 200 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746892 | Tiocystin 200 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746892 | Tiocystin 200 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746893 | capsaicin 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2746894 | capsaicin 0.5 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746894 | capsaicin 0.5 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746894 | capsaicin 0.5 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746895 | calamine 5 % / menthol 0.44 % / zinc oxide 20.625 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746895 | calamine 5 % / menthol 0.44 % / zinc oxide 20.625 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746895 | calamine 5 % / menthol 0.44 % / zinc oxide 20.625 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746895 | calamine 5 % / menthol 0.44 % / zinc oxide 20.625 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746896 | Toxicodendron radicans whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2746957 | enrofloxacin 136 MG [Enroflox] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2746958 | Enroflox 136 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746958 | Enroflox 136 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746958 | Enroflox 136 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2746959 | fluorouracil Injectable Solution [Favlyxa] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746960 | FAVLYXA 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746960 | FAVLYXA 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746960 | FAVLYXA 25 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746960 | FAVLYXA 25 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746960 | FAVLYXA 25 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746961 | influenza A virus A/Missouri/11/2025 (H1N1) antigen 0.03 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2746964 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Missouri/Tokyo) 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2746964 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Missouri/Tokyo) 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746964 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Missouri/Tokyo) 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746965 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Missouri/Tokyo) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2746965 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Missouri/Tokyo) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746965 | influenza virus vaccine 2026-2027 (trivalent - Michigan/Missouri/Tokyo) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746966 | Fluad 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2746967 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Missouri/11/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML [Fluad 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2746968 | Fluad 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2746969 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluad 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2746971 | FLUAD 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2746971 | FLUAD 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2746971 | FLUAD 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2746972 | FLUAD 2026-2027 vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2746972 | FLUAD 2026-2027 vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2746972 | FLUAD 2026-2027 vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747109 | thrombin, bovine 1000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747110 | thrombin, bovine 1000 UNT in 1 mL Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747110 | thrombin, bovine 1000 UNT in 1 mL Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747110 | thrombin, bovine 1000 UNT in 1 mL Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747110 | thrombin, bovine 1000 UNT in 1 mL Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747111 | thrombin, bovine 1000 UNT/ML [Thrombin-JMI] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747112 | Thrombin-JMI 1000 UNT in 1 ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747112 | Thrombin-JMI 1000 UNT in 1 ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747112 | Thrombin-JMI 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747112 | Thrombin-JMI 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747112 | Thrombin-JMI 1000 UNT in 1 ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747114 | activated charcoal 0.3 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2747115 | sodium sulfate 0.0625 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2747116 | activated charcoal / sodium sulfate | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2747117 | activated charcoal / sodium sulfate Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2747118 | activated charcoal / sodium sulfate Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2747119 | activated charcoal / sodium sulfate Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2747120 | activated charcoal 300 MG / sodium sulfate 62.5 MG in 1 mL Oral Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747120 | activated charcoal 300 MG / sodium sulfate 62.5 MG in 1 mL Oral Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747120 | activated charcoal 300 MG / sodium sulfate 62.5 MG in 1 mL Oral Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747121 | activated charcoal Oral Gel Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2747122 | activated charcoal Oral Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2747123 | activated charcoal 300 MG in 1 mL Oral Gels | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747123 | activated charcoal 300 MG in 1 mL Oral Gels | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747123 | activated charcoal 300 MG in 1 mL Oral Gels | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747124 | terbinafine 10 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2747127 | terbinafine 1 % / undecylenic acid 25 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747127 | terbinafine 1 % / undecylenic acid 25 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747127 | terbinafine 1 % / undecylenic acid 25 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747128 | tislelizumab-jsgr 150 MG in 15 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747128 | tislelizumab-jsgr 150 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747128 | tislelizumab-jsgr 150 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747129 | TEVIMBRA 150 MG in 15 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747129 | TEVIMBRA 150 MG in 15 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747129 | TEVIMBRA 150 MG in 15 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747131 | isatuximab-irfc 140 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747132 | isatuximab-irfc 1400 MG in 10 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747132 | isatuximab-irfc 1400 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747132 | isatuximab-irfc 1400 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747133 | isatuximab-irfc 140 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747133 | isatuximab-irfc 140 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747134 | isatuximab-irfc 140 MG/ML [Sarclisa] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747135 | SARCLISA ESCENA 1400 MG in 10 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747135 | SARCLISA ESCENA 1400 MG in 10 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747135 | SARCLISA ESCENA 1400 MG in 10 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747136 | SARCLISA 140 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747136 | SARCLISA 140 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747136 | SARCLISA 140 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747137 | sodium bicarbonate 12.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747138 | sodium bicarbonate 150 mEq in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747138 | sodium bicarbonate 150 mEq in 1000 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747138 | sodium bicarbonate 150 mEq in 1000 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747138 | sodium bicarbonate 150 mEq in 1000 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747139 | NaHCO3 12.6 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747139 | NaHCO3 12.6 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747147 | miconazole Vaginal Gel | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2747149 | miconazole nitrate 2 % Vaginal Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747149 | miconazole nitrate 2 % Vaginal Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747149 | miconazole nitrate 2 % Vaginal Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747150 | magnesium chloride 20 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2747151 | lidocaine / magnesium chloride / menthol | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | NO |
| RxCUI: 2747152 | lidocaine / magnesium chloride / menthol Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2747153 | lidocaine / magnesium chloride / menthol Topical Cream | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2747156 | lidocaine HCl 1 % / magnesium chloride 2 % / menthol 3.7 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747156 | lidocaine HCl 1 % / magnesium chloride 2 % / menthol 3.7 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747156 | lidocaine HCl 1 % / magnesium chloride 2 % / menthol 3.7 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747209 | atacicept | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747210 | ethinyl estradiol 0.000417 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747211 | levonorgestrel 0.00167 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747214 | ethinyl estradiol 0.000417 MG/HR / levonorgestrel 0.00167 MG/HR [Twirla] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747219 | menthol 44.9 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2747220 | menthol 4.49 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747220 | menthol 4.49 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747220 | menthol 4.49 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747227 | busPIRone HCl 5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2747228 | buspirone hydrochloride 5 MG [Bucapsol] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747228 | buspirone hydrochloride 5 MG [Bucapsol] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2747229 | Bucapsol 5 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747229 | Bucapsol 5 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747229 | Bucapsol 5 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747229 | Bucapsol 5 MG Oral Capsule | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2747231 | atacicept-vymj | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2747232 | atacicept-vymj 150 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747233 | atacicept Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747234 | atacicept Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747237 | atacicept-vymj 150 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747237 | atacicept-vymj 150 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747237 | atacicept-vymj 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747238 | atacicept-vymj 150 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747239 | Trutakna | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747240 | atacicept-vymj 150 MG/ML [Trutakna] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747241 | Trutakna Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747242 | atacicept Auto-Injector [Trutakna] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747244 | Trutakna 150 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747244 | Trutakna 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747244 | Trutakna 150 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747244 | Trutakna 150 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747245 | atacicept-vymj 150 MG/ML Auto-Injector [Trutakna] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747245 | atacicept-vymj 150 MG/ML Auto-Injector [Trutakna] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747246 | Flulaval 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747247 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML [Flulaval 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747248 | Flulaval 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747249 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Flulaval 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747251 | FLULAVAL 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747251 | FLULAVAL 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747251 | FLULAVAL 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747252 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML Prefilled Syringe [Flulaval 2026-2027] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747253 | denosumab-desu 70 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747255 | denosumab-desu 120 MG in 1.7 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747255 | denosumab-desu 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747255 | denosumab-desu 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747256 | denosumab-desu 70 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747257 | Jubereq | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747258 | denosumab-desu 70 MG/ML [Jubereq] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747259 | Jubereq Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747260 | denosumab Injection [Jubereq] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747262 | JUBEREQ 120 MG in 1.7 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747262 | JUBEREQ 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747262 | JUBEREQ 120 MG in 1.7 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747262 | JUBEREQ 120 MG in 1.7 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747263 | denosumab-desu 70 MG/ML Injection [Jubereq] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747263 | denosumab-desu 70 MG/ML Injection [Jubereq] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747290 | beclomethasone / formoterol / glycopyrronium | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 2747291 | beclomethasone / formoterol / glycopyrronium Inhalant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747292 | beclomethasone / formoterol / glycopyrronium Metered Dose Inhaler | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747295 | beclomethasone dipropionate 86 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler, 120 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747295 | beclomethasone dipropionate 86 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747295 | beclomethasone dipropionate 86 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747296 | beclomethasone dipropionate 86 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747296 | beclomethasone dipropionate 86 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747296 | beclomethasone dipropionate 86 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747297 | Trimbow | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747299 | Trimbow Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747300 | beclomethasone / formoterol / glycopyrronium Metered Dose Inhaler [Trimbow] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747302 | Trimbow 86/4.9/10.6 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747302 | Trimbow 86/4.9/10.6 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747302 | Trimbow 86/4.9/10.6 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747303 | Trimbow 86/4.9/10.6 MCG/INHAL Metered Dose Inhaler | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747303 | Trimbow 86/4.9/10.6 MCG/INHAL Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747303 | Trimbow 86/4.9/10.6 MCG/INHAL Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747306 | endoglin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Designated preferred name (PT) | NO | |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Designated preferred name (PT) | NO | |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Designated preferred name (PT) | NO | |
| RxCUI: 2747307 | Pyrimidine 5'-nucleotidase | Full form of descriptor (FN) | NO | |
| RxCUI: 2747308 | Thy-1 membrane glycoprotein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Designated preferred name (PT) | NO | |
| RxCUI: 2747309 | Intercellular adhesion molecule 1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2747310 | human hepatocyte growth factor | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2747312 | beclomethasone dipropionate 172 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler, 120 Actuations | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747312 | beclomethasone dipropionate 172 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747312 | beclomethasone dipropionate 172 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747313 | beclomethasone dipropionate 172 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747313 | beclomethasone dipropionate 172 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747313 | beclomethasone dipropionate 172 MCG/ACTUAT / formoterol fumarate 4.9 MCG/ACTUAT / glycopyrrolate 10.6 MCG/ACTUAT Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747315 | Trimbow 172/4.9/10.6 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747315 | Trimbow 172/4.9/10.6 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747315 | Trimbow 172/4.9/10.6 MCG/INHAL Metered Dose Inhaler, 120 Actuations | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747316 | Trimbow 172/4.9/10.6 MCG/INHAL Metered Dose Inhaler | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747316 | Trimbow 172/4.9/10.6 MCG/INHAL Metered Dose Inhaler | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747316 | Trimbow 172/4.9/10.6 MCG/INHAL Metered Dose Inhaler | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747347 | filgrastim-laha | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2747348 | filgrastim-laha 0.6 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747351 | filgrastim-laha 300 MCG in 0.5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747351 | filgrastim-laha 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747351 | filgrastim-laha 300 MCG in 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747351 | filgrastim-laha 300 MCG in 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747352 | filgrastim-laha 0.6 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747353 | Filkri | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747354 | filgrastim-laha 0.6 MG/ML [Filkri] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747355 | Filkri Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747356 | filgrastim Prefilled Syringe [Filkri] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747358 | FILKRI 300 MCG per 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747358 | FILKRI 300 MCG per 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747358 | FILKRI 300 MCG per 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747358 | FILKRI 300 MCG per 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747359 | filgrastim-laha 0.6 MG/ML Prefilled Syringe [Filkri] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747359 | filgrastim-laha 0.6 MG/ML Prefilled Syringe [Filkri] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747360 | filgrastim-laha 480 MCG in 0.8 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747360 | filgrastim-laha 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747360 | filgrastim-laha 480 MCG in 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747360 | filgrastim-laha 480 MCG in 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747361 | FILKRI 480 MCG per 0.8 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747361 | FILKRI 480 MCG per 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747361 | FILKRI 480 MCG per 0.8 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747361 | FILKRI 480 MCG per 0.8 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747362 | camphor 59 MG / levomenthol 8 MG / methyl salicylate 46 MG in 1 GM Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747362 | camphor 59 MG / levomenthol 8 MG / methyl salicylate 46 MG in 1 GM Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747366 | allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2747367 | allogeneic regulatory T cell immunotherapy with HSPC and T cells | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747368 | allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747369 | allogeneic regulatory T cell immunotherapy with HSPC and T cells Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747370 | allogeneic regulatory T cell immunotherapy with HSPC and T cells Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747373 | allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747373 | allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747374 | Tregzi | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747375 | allogeneic regulatory T cell immunotherapy with HSPC and T cells-vldq 1 UNT [Tregzi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747376 | Tregzi Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747377 | allogeneic regulatory T cell immunotherapy with HSPC and T cells Injection [Tregzi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747379 | TREGZI Cell Suspension for Infusion | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747379 | TREGZI Cell Suspension for Infusion | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747379 | TREGZI Cell Suspension for Infusion | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747380 | CD34 enriched allogeneic human hematopoietic stem and progenitor cells | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747381 | leukocyte antigen matched allogeneic human regulatory T cells | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747382 | leukocyte antigen matched allogeneic human T cells | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747384 | betamethasone / calcipotriene Topical Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747387 | Attero | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747388 | betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML [Attero] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747389 | Attero Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747390 | betamethasone / calcipotriene Topical Suspension [Attero] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747392 | ATTERO 0.064 % / 0.005 % Topical Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747392 | ATTERO 0.064 % / 0.005 % Topical Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747392 | ATTERO 0.064 % / 0.005 % Topical Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747481 | buprenorphine 12 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747481 | buprenorphine 12 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747481 | buprenorphine 12 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747482 | buprenorphine 4 MG Sublingual Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747482 | buprenorphine 4 MG Sublingual Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747482 | buprenorphine 4 MG Sublingual Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747503 | lidocaine 350 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747504 | lidocaine 35 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747504 | lidocaine 35 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747504 | lidocaine 35 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747506 | nilotinib 60 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747507 | nilotinib Disintegrating Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747508 | nilotinib Disintegrating Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747509 | nilotinib 60 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747509 | nilotinib 60 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747509 | nilotinib 60 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747510 | Cavhanza | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747511 | nilotinib 60 MG [Cavhanza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747512 | Cavhanza Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747513 | Cavhanza Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747514 | Cavhanza Disintegrating Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747515 | nilotinib Disintegrating Oral Tablet [Cavhanza] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747516 | CAVHANZA 60 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747516 | CAVHANZA 60 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747516 | CAVHANZA 60 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747517 | nilotinib 80 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747518 | nilotinib 80 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747518 | nilotinib 80 MG Disintegrating Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747518 | nilotinib 80 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747519 | nilotinib 80 MG [Cavhanza] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747520 | CAVHANZA 80 MG Disintegrating Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747520 | CAVHANZA 80 MG Disintegrating Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747520 | CAVHANZA 80 MG Disintegrating Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747523 | betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML [Taclonex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747524 | betamethasone / calcipotriene Topical Suspension [Taclonex] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747527 | betamethasone dipropionate 0.000643 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747530 | betamethasone dipropionate 0.000643 MG/MG / calcipotriene 0.00005 MG/MG [Taclonex] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 27476 | Immunosuppressive acidic protein | Designated preferred name (PT) | NO | |
| RxCUI: 27476 | Immunosuppressive acidic protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2747657 | etuvetidigene autotemcel | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747658 | etuvetidigene autotemcel 11400000 CELLS/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747659 | etuvetidigene autotemcel Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747660 | etuvetidigene autotemcel Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747661 | etuvetidigene autotemcel 11,400,000 CELLS/ML in 20 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747661 | etuvetidigene autotemcel 11,400,000 CELLS/ML in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747661 | etuvetidigene autotemcel 11,400,000 CELLS/ML in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747662 | etuvetidigene autotemcel 11400000 CELLS/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747663 | Waskyra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747664 | etuvetidigene autotemcel 11400000 CELLS/ML [Waskyra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747665 | Waskyra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747666 | etuvetidigene autotemcel Injection [Waskyra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747667 | Waskyra 11,400,000 CELLS/ML in 20 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747667 | Waskyra 11,400,000 CELLS/ML in 20 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747667 | Waskyra 11,400,000 CELLS/ML in 20 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747668 | etuvetidigene autotemcel 11400000 CELLS/ML Injection [Waskyra] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747668 | etuvetidigene autotemcel 11400000 CELLS/ML Injection [Waskyra] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747669 | influenza A virus A/Darwin/1369/2025 (H3N2) antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2747670 | influenza B virus B/Perth/115/2025 antigen | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2747671 | lefamulin 600 MG Oral Tablet, 5-Day, 10-Dose Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2747671 | lefamulin 600 MG Oral Tablet, 5-Day, 10-Dose Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747671 | lefamulin 600 MG Oral Tablet, 5-Day, 10-Dose Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747672 | Xenleta 600 MG, 5-Day, 10-Count Pack | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2747672 | Xenleta 600 MG, 5-Day, 10-Count Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747672 | Xenleta 600 MG, 5-Day, 10-Count Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747673 | piroctone olamine 0.005 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2747674 | piroctone olamine Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2747675 | piroctone olamine Topical Powder | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2747676 | piroctone olamine 0.5 % Topical Powder | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747676 | piroctone olamine 0.5 % Topical Powder | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747676 | piroctone olamine 0.5 % Topical Powder | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747677 | influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747678 | influenza A virus A/Darwin/1369/2025 (H3N2) antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747679 | influenza B virus B/Perth/115/2025 antigen 158000000 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747683 | influenza virus vaccine 2026-2027 Nasal Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747683 | influenza virus vaccine 2026-2027 Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747683 | influenza virus vaccine 2026-2027 Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747684 | FluMist 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747685 | influenza A virus A/Darwin/1369/2025 (H3N2) antigen 158000000 UNT/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 158000000 UNT/ML / influenza B virus B/Perth/115/2025 antigen 158000000 UNT/ML [FluMist 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747686 | FluMist 2026-2027 Inhalant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747687 | FluMist 2026-2027 Nasal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747688 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Nasal Spray [FluMist 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747690 | FluMist 2026-2027 Formula Nasal Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747690 | FluMist 2026-2027 Formula Nasal Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747690 | FluMist 2026-2027 Formula Nasal Spray | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747691 | fenbendazole Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2747692 | fenbendazole 222 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2747692 | fenbendazole 222 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747694 | influenza virus vaccine 2026-2027 Nasal Spray (Home Administration) | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747694 | influenza virus vaccine 2026-2027 Nasal Spray (Home Administration) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747694 | influenza virus vaccine 2026-2027 Nasal Spray (Home Administration) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747695 | FluMist 2026-2027 Formula Nasal Spray (Home Administration) | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747695 | FluMist 2026-2027 Formula Nasal Spray (Home Administration) | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747695 | FluMist 2026-2027 Formula Nasal Spray (Home Administration) | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 274771 | Nelarabine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 274771 | Nelarabine | Designated preferred name (PT) | YES | |
| RxCUI: 274771 | Nelarabine | Full form of descriptor (FN) | YES | |
| RxCUI: 274771 | Nelarabine | Designated preferred name (PT) | YES | |
| RxCUI: 274771 | Nelarabine | Full form of descriptor (FN) | YES | |
| RxCUI: 2747749 | dichloro(methylsulfonyl)methane | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747750 | enlicitide decanoate | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2747751 | enlicitide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747751 | enlicitide | Designated preferred name (PT) | YES | |
| RxCUI: 2747751 | enlicitide | Full form of descriptor (FN) | YES | |
| RxCUI: 2747751 | enlicitide | Designated preferred name (PT) | YES | |
| RxCUI: 2747751 | enlicitide | Full form of descriptor (FN) | YES | |
| RxCUI: 2747752 | enlicitide 20 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747753 | enlicitide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747754 | enlicitide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747755 | enlicitide Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747756 | enlicitide 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747756 | enlicitide 20 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747757 | Lipfendra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747758 | enlicitide 20 MG [Lipfendra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747759 | Lipfendra Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747760 | Lipfendra Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747761 | enlicitide Oral Tablet [Lipfendra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747762 | Lipfendra 20 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747762 | Lipfendra 20 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747762 | Lipfendra 20 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747763 | furosemide 80 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747764 | furosemide Auto-Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747765 | furosemide 80 MG in 1 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747765 | furosemide 80 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747765 | furosemide 80 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747766 | furosemide 80 MG/ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2747767 | furosemide 80 MG/ML [Furoscix] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747768 | furosemide Auto-Injector [Furoscix] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747769 | FUROSCIX 80 MG in 1 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747769 | FUROSCIX 80 MG in 1 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747769 | FUROSCIX 80 MG in 1 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747770 | furosemide 80 MG/ML Auto-Injector [Furoscix] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747770 | furosemide 80 MG/ML Auto-Injector [Furoscix] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2747771 | gedatolisib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747772 | gedatolisib 180 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2747773 | gedatolisib Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2747774 | gedatolisib Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2747775 | gedatolisib 180 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747775 | gedatolisib 180 MG Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747776 | Revtorpyk | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2747777 | gedatolisib 180 MG [Revtorpyk] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2747778 | Revtorpyk Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2747779 | gedatolisib Injection [Revtorpyk] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2747780 | REVTORPYK 180 MG Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747780 | REVTORPYK 180 MG Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747780 | REVTORPYK 180 MG Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747781 | hydrogenated C9 resin oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747782 | lecanemab-irmb 250 MG in 1.25 ML Auto-Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2747782 | lecanemab-irmb 250 MG in 1.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747782 | lecanemab-irmb 250 MG in 1.25 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747782 | lecanemab-irmb 250 MG in 1.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747783 | LEQEMBI IQLIK 250 MG in 1.25 ML Auto-Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2747783 | LEQEMBI IQLIK 250 MG in 1.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747783 | LEQEMBI IQLIK 250 MG in 1.25 ML Auto-Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747783 | LEQEMBI IQLIK 250 MG in 1.25 ML Auto-Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2747784 | menthyl nicotinate, (-)- | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747785 | sodium decanoate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2747785 | sodium decanoate | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2747787 | Product containing only solifenacin and tamsulosin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747787 | Product containing only solifenacin and tamsulosin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747788 | Product containing only somatrogon (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747788 | Product containing only somatrogon (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747789 | Product containing only sparsentan (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747789 | Product containing only sparsentan (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747790 | Product containing only sparsentan in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747790 | Product containing only sparsentan in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747791 | Group B Streptococcus vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747791 | Group B Streptococcus vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747791 | Group B Streptococcus vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747792 | Cetilistat only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747792 | Cetilistat only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747793 | Cetilistat only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747793 | Cetilistat only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747794 | Product containing only sutimlimab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747794 | Product containing only sutimlimab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747795 | Product containing only sutimlimab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747795 | Product containing only sutimlimab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747796 | Clonixin and cyanocobalamin and pyridoxine and thiamine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747796 | Clonixin and cyanocobalamin and pyridoxine and thiamine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747797 | Clonixin and cyclobenzaprine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747797 | Clonixin and cyclobenzaprine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747798 | Clonixin and cyproheptadine and ergotamine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747798 | Clonixin and cyproheptadine and ergotamine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747799 | Clonixin and ergotamine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747799 | Clonixin and ergotamine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747800 | Clonixin and ergotamine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747800 | Clonixin and ergotamine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747801 | Clonixin and pargeverine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747801 | Clonixin and pargeverine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747802 | Clonixin and pargeverine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747802 | Clonixin and pargeverine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747803 | Clonixin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747803 | Clonixin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747804 | Clonixin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747804 | Clonixin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747805 | Clonixin only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747805 | Clonixin only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747806 | Inactivated whole cell Bordetella pertussis vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747806 | Inactivated whole cell Bordetella pertussis vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747806 | Inactivated whole cell Bordetella pertussis vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747807 | Inavolisib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747807 | Inavolisib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747808 | Influenza and SARS-CoV-2 antigens vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747808 | Influenza and SARS-CoV-2 antigens vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747808 | Influenza and SARS-CoV-2 antigens vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747808 | Influenza and SARS-CoV-2 antigens vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747809 | Influenza virus mRNA vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747809 | Influenza virus mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747809 | Influenza virus mRNA vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747810 | Product containing only teclistamab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747810 | Product containing only teclistamab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747811 | Product containing only tegoprazan (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747811 | Product containing only tegoprazan (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747812 | Product containing only tegoprazan in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747812 | Product containing only tegoprazan in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747813 | Product containing only terizidone (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747813 | Product containing only terizidone (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747814 | Arginine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747814 | Arginine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747815 | Iptacopan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747815 | Iptacopan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747816 | Iptacopan only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747816 | Iptacopan only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747817 | Landiolol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747817 | Landiolol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747818 | Landiolol only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747818 | Landiolol only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747819 | Laropiprant and nicotinic acid only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747819 | Laropiprant and nicotinic acid only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747819 | Laropiprant and nicotinic acid only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747820 | Product containing only tilmanocept (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747820 | Product containing only tilmanocept (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747821 | Product containing only tisopurine (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747821 | Product containing only tisopurine (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747822 | Tocofersolan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747822 | Tocofersolan only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747822 | Tocofersolan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747823 | Product containing only topiroxostat (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747823 | Product containing only topiroxostat (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747824 | Product containing only topiroxostat in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747824 | Product containing only topiroxostat in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747825 | Product containing only trelagliptin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747825 | Product containing only trelagliptin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747826 | Product containing only trelagliptin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747826 | Product containing only trelagliptin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747827 | Product containing only tremelimumab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747827 | Product containing only tremelimumab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747828 | Aspirin and atorvastatin and ramipril only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747828 | Aspirin and atorvastatin and ramipril only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747829 | Atogepant only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747829 | Atogepant only product | Full form of descriptor (FN) | NO | |
| RxCUI: 274783 | Insulin glargine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 274783 | Insulin glargine | Designated preferred name (PT) | YES | |
| RxCUI: 274783 | Insulin glargine | Full form of descriptor (FN) | YES | |
| RxCUI: 274783 | Insulin glargine | Designated preferred name (PT) | YES | |
| RxCUI: 274783 | Insulin glargine | Full form of descriptor (FN) | YES | |
| RxCUI: 2747830 | Atogepant only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747830 | Atogepant only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747831 | Cobicistat and darunavir and emtricitabine and tenofovir only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747831 | Cobicistat and darunavir and emtricitabine and tenofovir only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747832 | Colestilan only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747832 | Colestilan only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747832 | Colestilan only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747833 | Linvoseltamab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747833 | Linvoseltamab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747834 | Linvoseltamab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747834 | Linvoseltamab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747835 | Live attenuated poliovirus serotype 1, 2 and 3 vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747835 | Live attenuated poliovirus serotype 1, 2 and 3 vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747835 | Live attenuated poliovirus serotype 1, 2 and 3 vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747836 | Azelnidipine and metoprolol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747836 | Azelnidipine and metoprolol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747837 | Azelnidipine and metoprolol only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747837 | Azelnidipine and metoprolol only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747838 | Azelnidipine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747838 | Azelnidipine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747839 | Azelnidipine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747839 | Azelnidipine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747840 | Dextromethorphan and quinidine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747840 | Dextromethorphan and quinidine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747841 | Cinchocaine and esculin and framycetin and hydrocortisone only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747841 | Cinchocaine and esculin and framycetin and hydrocortisone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747841 | Cinchocaine and esculin and framycetin and hydrocortisone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747842 | Diclofenac and pridinol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747842 | Diclofenac and pridinol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747843 | Lobeglitazone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747843 | Lobeglitazone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747844 | Lobeglitazone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747844 | Lobeglitazone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747845 | Product containing only volanesorsen (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747845 | Product containing only volanesorsen (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747846 | Product containing only volanesorsen in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747846 | Product containing only volanesorsen in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747847 | Product containing only vonicog alfa (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747847 | Product containing only vonicog alfa (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747848 | Product containing only vonicog alfa in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747848 | Product containing only vonicog alfa in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747849 | Product containing only vonoprazan (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747849 | Product containing only vonoprazan (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747850 | Product containing only vonoprazan in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747850 | Product containing only vonoprazan in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747851 | Delgocitinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747851 | Delgocitinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747852 | Delgocitinib only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747852 | Delgocitinib only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747853 | Desidustat only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747853 | Desidustat only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747854 | Desidustat only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747854 | Desidustat only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747855 | Dixyrazine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747855 | Dixyrazine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747856 | Dixyrazine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747856 | Dixyrazine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747857 | Donanemab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747857 | Donanemab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747858 | Donanemab only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747858 | Donanemab only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747859 | Durlobactam and sulbactam only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747859 | Durlobactam and sulbactam only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 274786 | telithromycin | Full form of descriptor (FN) | NO | |
| RxCUI: 274786 | telithromycin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 274786 | telithromycin | Designated preferred name (PT) | NO | |
| RxCUI: 274786 | telithromycin | Full form of descriptor (FN) | NO | |
| RxCUI: 274786 | telithromycin | Designated preferred name (PT) | NO | |
| RxCUI: 2747861 | Elacestrant only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747861 | Elacestrant only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747862 | Elobixibat only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747862 | Elobixibat only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747863 | Elobixibat only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747863 | Elobixibat only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747864 | Meloxicam and pridinol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747864 | Meloxicam and pridinol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747865 | Metamizole and pargeverine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747865 | Metamizole and pargeverine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747866 | Metamizole and pargeverine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747866 | Metamizole and pargeverine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747867 | Metamizole only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747867 | Metamizole only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747868 | Mifamurtide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747868 | Mifamurtide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747869 | Mobocertinib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747869 | Mobocertinib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747870 | Momelotinib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747870 | Momelotinib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747871 | Product containing only vorasidenib (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747871 | Product containing only vorasidenib (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747872 | Product containing only zamtocabtagene autoleucel (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747872 | Product containing only zamtocabtagene autoleucel (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747873 | Product containing only zamtocabtagene autoleucel in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747873 | Product containing only zamtocabtagene autoleucel in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747874 | Product containing only zolbetuximab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747874 | Product containing only zolbetuximab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747875 | Product containing only zolbetuximab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747875 | Product containing only zolbetuximab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747876 | Brensocatib only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747876 | Brensocatib only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747877 | Brensocatib only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747877 | Brensocatib only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747878 | Ethinyl estradiol and etonogestrel only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747878 | Ethinyl estradiol and etonogestrel only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747878 | Ethinyl estradiol and etonogestrel only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747879 | Bulevirtide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747879 | Bulevirtide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747880 | Bulevirtide only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747880 | Bulevirtide only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747881 | Busulfan only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747881 | Busulfan only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747882 | Cantharidin and Podophyllum resin and salicylic acid only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747882 | Cantharidin and Podophyllum resin and salicylic acid only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747883 | Evogliptin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747883 | Evogliptin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747884 | Evogliptin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747884 | Evogliptin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747885 | Meningococcus A, B, C, W and Y vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747885 | Meningococcus A, B, C, W and Y vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747885 | Meningococcus A, B, C, W and Y vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747886 | Meningococcus serogroup B and C vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747886 | Meningococcus serogroup B and C vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747886 | Meningococcus serogroup B and C vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747886 | Meningococcus serogroup B and C vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747887 | Nirsevimab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747887 | Nirsevimab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747888 | Nivolumab and relatlimab only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747888 | Nivolumab and relatlimab only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747889 | Olezarsen only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747889 | Olezarsen only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747890 | RSV (respiratory syncytial virus) mRNA vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747890 | RSV (respiratory syncytial virus) mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747890 | RSV (respiratory syncytial virus) mRNA vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747890 | RSV (respiratory syncytial virus) mRNA vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747891 | Palovarotene only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747891 | Palovarotene only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747892 | Pargeverine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747892 | Pargeverine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747893 | Pargeverine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747893 | Pargeverine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747894 | Pargeverine only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747894 | Pargeverine only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747895 | Glimepiride and lobeglitazone only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747895 | Glimepiride and lobeglitazone only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747896 | Glimepiride and lobeglitazone only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747896 | Glimepiride and lobeglitazone only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747897 | Pinaverium bromide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747897 | Pinaverium bromide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747898 | Gozetotide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747898 | Gozetotide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747899 | Gozetotide only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747899 | Gozetotide only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747900 | Pridinol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747900 | Pridinol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747901 | Pristinamycin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747901 | Pristinamycin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747902 | Pristinamycin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747902 | Pristinamycin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747903 | Product containing only quizartinib (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747903 | Product containing only quizartinib (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747904 | Product containing only quizartinib in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747904 | Product containing only quizartinib in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747905 | Product containing only raxtozinameran (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747905 | Product containing only raxtozinameran (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747906 | Product containing only raxtozinameran in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747906 | Product containing only raxtozinameran in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747907 | Product containing only regdanvimab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747907 | Product containing only regdanvimab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747908 | Iguratimod only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747908 | Iguratimod only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747909 | Iguratimod only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747909 | Iguratimod only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747910 | Product containing only rozanolixizumab (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747910 | Product containing only rozanolixizumab (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747911 | Paratyphoid A and Paratyphoid B and Typhoid vaccine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747911 | Paratyphoid A and Paratyphoid B and Typhoid vaccine | Designated preferred name (PT) | NO | |
| RxCUI: 2747911 | Paratyphoid A and Paratyphoid B and Typhoid vaccine | Full form of descriptor (FN) | NO | |
| RxCUI: 2747912 | Alfatradiol only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747912 | Alfatradiol only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747913 | Alfatradiol only product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747913 | Alfatradiol only product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747914 | Aluminium hydroxide and niflumic acid and orphenadrine only product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747914 | Aluminium hydroxide and niflumic acid and orphenadrine only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747914 | Aluminium hydroxide and niflumic acid and orphenadrine only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747915 | Aluminium hydroxide and niflumic acid and orphenadrine only product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747915 | Aluminium hydroxide and niflumic acid and orphenadrine only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747915 | Aluminium hydroxide and niflumic acid and orphenadrine only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747916 | Imeglimin only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747916 | Imeglimin only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747917 | Imeglimin only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747917 | Imeglimin only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747918 | Imlifidase only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747918 | Imlifidase only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747919 | Imlifidase only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747919 | Imlifidase only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747920 | Product containing only silymarin (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747920 | Product containing only silymarin (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747921 | Product containing only silymarin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747921 | Product containing only silymarin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2747922 | Product containing only sinecatechins (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2747922 | Product containing only sinecatechins (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2747923 | Amphotericin B phospholipid complex only product | Designated preferred name (PT) | NO | |
| RxCUI: 2747923 | Amphotericin B phospholipid complex only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747924 | Amphotericin B phospholipid complex only product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747924 | Amphotericin B phospholipid complex only product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747925 | Ampicillin and sulbactam only product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2747925 | Ampicillin and sulbactam only product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2747926 | Antigen of Mycobacterium tuberculosis recombinant culture filtrate protein 10 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747926 | Antigen of Mycobacterium tuberculosis recombinant culture filtrate protein 10 kilodalton | Full form of descriptor (FN) | NO | |
| RxCUI: 2747926 | Antigen of Mycobacterium tuberculosis recombinant culture filtrate protein 10 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747926 | Antigen of Mycobacterium tuberculosis recombinant culture filtrate protein 10 kilodalton | Designated preferred name (PT) | NO | |
| RxCUI: 2747926 | Antigen of Mycobacterium tuberculosis recombinant culture filtrate protein 10 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747927 | Immunoglobulin G antibody to Solidago virgaurea | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747927 | Immunoglobulin G antibody to Solidago virgaurea | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747927 | Immunoglobulin G antibody to Solidago virgaurea | Full form of descriptor (FN) | NO | |
| RxCUI: 2747927 | Immunoglobulin G antibody to Solidago virgaurea | Designated preferred name (PT) | NO | |
| RxCUI: 2747928 | Immunoglobulin G antibody to Spondylocladium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747928 | Immunoglobulin G antibody to Spondylocladium | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747928 | Immunoglobulin G antibody to Spondylocladium | Full form of descriptor (FN) | NO | |
| RxCUI: 2747928 | Immunoglobulin G antibody to Spondylocladium | Designated preferred name (PT) | NO | |
| RxCUI: 2747929 | Immunoglobulin G antibody to Stachybotrys chartarum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747929 | Immunoglobulin G antibody to Stachybotrys chartarum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747929 | Immunoglobulin G antibody to Stachybotrys chartarum | Full form of descriptor (FN) | NO | |
| RxCUI: 2747929 | Immunoglobulin G antibody to Stachybotrys chartarum | Designated preferred name (PT) | NO | |
| RxCUI: 2747930 | Immunoglobulin G antibody to Stemphylium botryosum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747930 | Immunoglobulin G antibody to Stemphylium botryosum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747930 | Immunoglobulin G antibody to Stemphylium botryosum | Full form of descriptor (FN) | NO | |
| RxCUI: 2747930 | Immunoglobulin G antibody to Stemphylium botryosum | Designated preferred name (PT) | NO | |
| RxCUI: 2747931 | Streptococcus agalactiae antigen-containing vaccine product | Designated preferred name (PT) | NO | |
| RxCUI: 2747931 | Streptococcus agalactiae antigen-containing vaccine product | Full form of descriptor (FN) | NO | |
| RxCUI: 2747932 | Anti-Chaetomium globosum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747932 | Anti-Chaetomium globosum IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747932 | Anti-Chaetomium globosum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747932 | Anti-Chaetomium globosum IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747933 | Anti-Ictalurus punctatus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747933 | Anti-Ictalurus punctatus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747933 | Anti-Ictalurus punctatus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747933 | Anti-Ictalurus punctatus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747933 | Anti-Ictalurus punctatus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747933 | Anti-Ictalurus punctatus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747934 | Anti-Gallus gallus meat IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747934 | Anti-Gallus gallus meat IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747934 | Anti-Gallus gallus meat IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747934 | Anti-Gallus gallus meat IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747934 | Anti-Gallus gallus meat IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747934 | Anti-Gallus gallus meat IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747935 | Immunoglobulin G antibody to Lolium perenne | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747935 | Immunoglobulin G antibody to Lolium perenne | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747935 | Immunoglobulin G antibody to Lolium perenne | Full form of descriptor (FN) | NO | |
| RxCUI: 2747935 | Immunoglobulin G antibody to Lolium perenne | Designated preferred name (PT) | NO | |
| RxCUI: 2747935 | Immunoglobulin G antibody to Lolium perenne | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747936 | Anti-Aspergillus amstelodami IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747936 | Anti-Aspergillus amstelodami IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747936 | Anti-Aspergillus amstelodami IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747936 | Anti-Aspergillus amstelodami IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747937 | Anti-Aspergillus nidulans IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747937 | Anti-Aspergillus nidulans IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747937 | Anti-Aspergillus nidulans IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747937 | Anti-Aspergillus nidulans IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747938 | Anti-Aspergillus terreus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747938 | Anti-Aspergillus terreus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747938 | Anti-Aspergillus terreus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747938 | Anti-Aspergillus terreus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747939 | Anti-Aspergillus versicolor IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747939 | Anti-Aspergillus versicolor IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747939 | Anti-Aspergillus versicolor IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747939 | Anti-Aspergillus versicolor IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747940 | Anti-Clupea harengus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747940 | Anti-Clupea harengus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747940 | Anti-Clupea harengus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747940 | Anti-Clupea harengus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747940 | Anti-Clupea harengus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747940 | Anti-Clupea harengus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747941 | Anti-Helianthus annuus (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747942 | Immunoglobulin G antibody to Lens esculenta | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747942 | Immunoglobulin G antibody to Lens esculenta | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747942 | Immunoglobulin G antibody to Lens esculenta | Full form of descriptor (FN) | NO | |
| RxCUI: 2747942 | Immunoglobulin G antibody to Lens esculenta | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747942 | Immunoglobulin G antibody to Lens esculenta | Designated preferred name (PT) | NO | |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747943 | Anti-Raphanus sativus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747944 | Cereal rye (pollen specific) IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747945 | Anti-Curvularia lunata IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747945 | Anti-Curvularia lunata IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747945 | Anti-Curvularia lunata IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747945 | Anti-Curvularia lunata IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747946 | Anti-Curvularia spicifera IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747946 | Anti-Curvularia spicifera IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747946 | Anti-Curvularia spicifera IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747946 | Anti-Curvularia spicifera IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747947 | Anti-Cynodon dactylon IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747947 | Anti-Cynodon dactylon IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747947 | Anti-Cynodon dactylon IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747947 | Anti-Cynodon dactylon IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747947 | Anti-Cynodon dactylon IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747948 | Anti-Dendryphiella vinosa IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747948 | Anti-Dendryphiella vinosa IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747948 | Anti-Dendryphiella vinosa IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747948 | Anti-Dendryphiella vinosa IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747948 | Anti-Dendryphiella vinosa IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747949 | Anti-Anethum graveolens IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747949 | Anti-Anethum graveolens IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747949 | Anti-Anethum graveolens IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747949 | Anti-Anethum graveolens IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747949 | Anti-Anethum graveolens IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747950 | Anti-Mytilus edulis IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747950 | Anti-Mytilus edulis IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747950 | Anti-Mytilus edulis IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747950 | Anti-Mytilus edulis IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747950 | Anti-Mytilus edulis IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747951 | Immunoglobulin G antibody to Prosopis juliflora | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747951 | Immunoglobulin G antibody to Prosopis juliflora | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747951 | Immunoglobulin G antibody to Prosopis juliflora | Full form of descriptor (FN) | NO | |
| RxCUI: 2747951 | Immunoglobulin G antibody to Prosopis juliflora | Designated preferred name (PT) | NO | |
| RxCUI: 2747951 | Immunoglobulin G antibody to Prosopis juliflora | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747952 | Immunoglobulin G antibody to Morus alba | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747952 | Immunoglobulin G antibody to Morus alba | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747952 | Immunoglobulin G antibody to Morus alba | Full form of descriptor (FN) | NO | |
| RxCUI: 2747952 | Immunoglobulin G antibody to Morus alba | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747952 | Immunoglobulin G antibody to Morus alba | Designated preferred name (PT) | NO | |
| RxCUI: 2747953 | European privet IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747953 | European privet IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747953 | European privet IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747953 | European privet IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747953 | European privet IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747953 | European privet IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747954 | Curly dock IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747954 | Curly dock IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747954 | Curly dock IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747954 | Curly dock IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747954 | Curly dock IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747954 | Curly dock IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747954 | Curly dock IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747954 | Curly dock IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747955 | Immunoglobulin G antibody to Perca | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747955 | Immunoglobulin G antibody to Perca | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747955 | Immunoglobulin G antibody to Perca | Full form of descriptor (FN) | NO | |
| RxCUI: 2747955 | Immunoglobulin G antibody to Perca | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747955 | Immunoglobulin G antibody to Perca | Designated preferred name (PT) | NO | |
| RxCUI: 2747956 | Artemisia tridentata IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747956 | Artemisia tridentata IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747956 | Artemisia tridentata IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747956 | Artemisia tridentata IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747956 | Artemisia tridentata IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747957 | Anti-Juglans nigra IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747957 | Anti-Juglans nigra IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747957 | Anti-Juglans nigra IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747957 | Anti-Juglans nigra IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747957 | Anti-Juglans nigra IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747958 | Anti-Botrytis cinerea IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747958 | Anti-Botrytis cinerea IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747958 | Anti-Botrytis cinerea IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747958 | Anti-Botrytis cinerea IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747959 | Anti-Epicoccum purpurascens IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747959 | Anti-Epicoccum purpurascens IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747959 | Anti-Epicoccum purpurascens IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747959 | Anti-Epicoccum purpurascens IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747960 | Anti-Epidermophyton floccosum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747960 | Anti-Epidermophyton floccosum IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747960 | Anti-Epidermophyton floccosum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747960 | Anti-Epidermophyton floccosum IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747961 | Monoclonal immunoglobulin G1 | Designated preferred name (PT) | NO | |
| RxCUI: 2747961 | Monoclonal immunoglobulin G1 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747961 | Monoclonal immunoglobulin G1 | Full form of descriptor (FN) | NO | |
| RxCUI: 2747962 | Monoclonal immunoglobulin G2 | Designated preferred name (PT) | NO | |
| RxCUI: 2747962 | Monoclonal immunoglobulin G2 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747962 | Monoclonal immunoglobulin G2 | Full form of descriptor (FN) | NO | |
| RxCUI: 2747963 | Monoclonal immunoglobulin G3 | Designated preferred name (PT) | NO | |
| RxCUI: 2747963 | Monoclonal immunoglobulin G3 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747963 | Monoclonal immunoglobulin G3 | Full form of descriptor (FN) | NO | |
| RxCUI: 2747964 | Monoclonal immunoglobulin G4 | Designated preferred name (PT) | NO | |
| RxCUI: 2747964 | Monoclonal immunoglobulin G4 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747964 | Monoclonal immunoglobulin G4 | Full form of descriptor (FN) | NO | |
| RxCUI: 2747965 | Anti-budgerigar droppings IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747965 | Anti-budgerigar droppings IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747965 | Anti-budgerigar droppings IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747965 | Anti-budgerigar droppings IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747965 | Anti-budgerigar droppings IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747966 | Anti-budgerigar feathers IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747966 | Anti-budgerigar feathers IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747966 | Anti-budgerigar feathers IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747966 | Anti-budgerigar feathers IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747966 | Anti-budgerigar feathers IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747967 | Bombus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747967 | Bombus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747967 | Bombus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747967 | Bombus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747967 | Bombus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747968 | Anti-California encephalitis virus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747968 | Anti-California encephalitis virus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747968 | Anti-California encephalitis virus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747968 | Anti-California encephalitis virus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747969 | Anti-Ricinus communis IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747969 | Anti-Ricinus communis IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747969 | Anti-Ricinus communis IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747969 | Anti-Ricinus communis IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747969 | Anti-Ricinus communis IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747970 | Anti-Populus tremula IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747970 | Anti-Populus tremula IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747970 | Anti-Populus tremula IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747970 | Anti-Populus tremula IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747970 | Anti-Populus tremula IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747971 | Anti-Anguilla anguilla IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747971 | Anti-Anguilla anguilla IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747971 | Anti-Anguilla anguilla IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747971 | Anti-Anguilla anguilla IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747971 | Anti-Anguilla anguilla IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747971 | Anti-Anguilla anguilla IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747972 | Anti-Exserohilum rostratum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747972 | Anti-Exserohilum rostratum IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747972 | Anti-Exserohilum rostratum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747972 | Anti-Exserohilum rostratum IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747973 | Annual bursage IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747973 | Annual bursage IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747974 | Immunoglobulin G antibody to Mucor plumbeus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747974 | Immunoglobulin G antibody to Mucor plumbeus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747974 | Immunoglobulin G antibody to Mucor plumbeus | Full form of descriptor (FN) | NO | |
| RxCUI: 2747974 | Immunoglobulin G antibody to Mucor plumbeus | Designated preferred name (PT) | NO | |
| RxCUI: 2747975 | Immunoglobulin G antibody to Mucor racemosus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747975 | Immunoglobulin G antibody to Mucor racemosus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747975 | Immunoglobulin G antibody to Mucor racemosus | Full form of descriptor (FN) | NO | |
| RxCUI: 2747975 | Immunoglobulin G antibody to Mucor racemosus | Designated preferred name (PT) | NO | |
| RxCUI: 2747976 | Antigen of Mycobacterium tuberculosis recombinant dimer early secretory antigenic target 6 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747976 | Antigen of Mycobacterium tuberculosis recombinant dimer early secretory antigenic target 6 kilodalton | Full form of descriptor (FN) | NO | |
| RxCUI: 2747976 | Antigen of Mycobacterium tuberculosis recombinant dimer early secretory antigenic target 6 kilodalton | Designated preferred name (PT) | NO | |
| RxCUI: 2747976 | Antigen of Mycobacterium tuberculosis recombinant dimer early secretory antigenic target 6 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747976 | Antigen of Mycobacterium tuberculosis recombinant dimer early secretory antigenic target 6 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747977 | Anti-Fusarium oxysporum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747977 | Anti-Fusarium oxysporum IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747977 | Anti-Fusarium oxysporum IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747977 | Anti-Fusarium oxysporum IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747978 | Fusarium moniliforme IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747978 | Fusarium moniliforme IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747978 | Fusarium moniliforme IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747978 | Fusarium moniliforme IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747978 | Fusarium moniliforme IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747979 | Immunoglobulin G antibody to Neurospora sitophila | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747979 | Immunoglobulin G antibody to Neurospora sitophila | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747979 | Immunoglobulin G antibody to Neurospora sitophila | Full form of descriptor (FN) | NO | |
| RxCUI: 2747979 | Immunoglobulin G antibody to Neurospora sitophila | Designated preferred name (PT) | NO | |
| RxCUI: 2747980 | Immunoglobulin G antibody to Papaver somniferum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747980 | Immunoglobulin G antibody to Papaver somniferum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747980 | Immunoglobulin G antibody to Papaver somniferum | Full form of descriptor (FN) | NO | |
| RxCUI: 2747980 | Immunoglobulin G antibody to Papaver somniferum | Designated preferred name (PT) | NO | |
| RxCUI: 2747980 | Immunoglobulin G antibody to Papaver somniferum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747981 | Common mackerel IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747981 | Common mackerel IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747981 | Common mackerel IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747981 | Common mackerel IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747981 | Common mackerel IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747981 | Common mackerel IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747982 | Immunoglobulin G antibody to Paecilomyces | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747982 | Immunoglobulin G antibody to Paecilomyces | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747982 | Immunoglobulin G antibody to Paecilomyces | Full form of descriptor (FN) | NO | |
| RxCUI: 2747982 | Immunoglobulin G antibody to Paecilomyces | Designated preferred name (PT) | NO | |
| RxCUI: 2747983 | Glycoprotein 2 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747983 | Glycoprotein 2 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747983 | Glycoprotein 2 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747983 | Glycoprotein 2 IgA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747983 | Glycoprotein 2 IgA | Full form of descriptor (FN) | NO | |
| RxCUI: 2747983 | Glycoprotein 2 IgA | Designated preferred name (PT) | NO | |
| RxCUI: 2747984 | Glycoprotein 2 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747984 | Glycoprotein 2 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747984 | Glycoprotein 2 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747984 | Glycoprotein 2 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747984 | Glycoprotein 2 IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747984 | Glycoprotein 2 IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747985 | Immunoglobulin G antibody to Parmesan cheese | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747985 | Immunoglobulin G antibody to Parmesan cheese | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747985 | Immunoglobulin G antibody to Parmesan cheese | Full form of descriptor (FN) | NO | |
| RxCUI: 2747985 | Immunoglobulin G antibody to Parmesan cheese | Designated preferred name (PT) | NO | |
| RxCUI: 2747986 | Immunoglobulin G antibody to Penicillium brevicompactum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747986 | Immunoglobulin G antibody to Penicillium brevicompactum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747986 | Immunoglobulin G antibody to Penicillium brevicompactum | Full form of descriptor (FN) | NO | |
| RxCUI: 2747986 | Immunoglobulin G antibody to Penicillium brevicompactum | Designated preferred name (PT) | NO | |
| RxCUI: 2747987 | Immunoglobulin G antibody to Phoma | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747987 | Immunoglobulin G antibody to Phoma | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747987 | Immunoglobulin G antibody to Phoma | Full form of descriptor (FN) | NO | |
| RxCUI: 2747987 | Immunoglobulin G antibody to Phoma | Designated preferred name (PT) | NO | |
| RxCUI: 2747988 | Immunoglobulin G antibody to Phoma betae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747988 | Immunoglobulin G antibody to Phoma betae | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747988 | Immunoglobulin G antibody to Phoma betae | Full form of descriptor (FN) | NO | |
| RxCUI: 2747988 | Immunoglobulin G antibody to Phoma betae | Designated preferred name (PT) | NO | |
| RxCUI: 2747989 | Immunoglobulin G antibody to phosphatidate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747989 | Immunoglobulin G antibody to phosphatidate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747989 | Immunoglobulin G antibody to phosphatidate | Full form of descriptor (FN) | NO | |
| RxCUI: 2747989 | Immunoglobulin G antibody to phosphatidate | Designated preferred name (PT) | NO | |
| RxCUI: 2747990 | Immunoglobulin G antibody to phosphatidylserine-prothrombin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747990 | Immunoglobulin G antibody to phosphatidylserine-prothrombin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747990 | Immunoglobulin G antibody to phosphatidylserine-prothrombin complex | Full form of descriptor (FN) | NO | |
| RxCUI: 2747990 | Immunoglobulin G antibody to phosphatidylserine-prothrombin complex | Designated preferred name (PT) | NO | |
| RxCUI: 2747991 | Immunoglobulin M antibody to phosphatidylserine-prothrombin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747991 | Immunoglobulin M antibody to phosphatidylserine-prothrombin complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747991 | Immunoglobulin M antibody to phosphatidylserine-prothrombin complex | Full form of descriptor (FN) | NO | |
| RxCUI: 2747991 | Immunoglobulin M antibody to phosphatidylserine-prothrombin complex | Designated preferred name (PT) | NO | |
| RxCUI: 2747992 | Columba livia feather IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747992 | Columba livia feather IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747992 | Columba livia feather IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747992 | Columba livia feather IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747992 | Columba livia feather IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747993 | Immunoglobulin G antibody to Pullularia | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747993 | Immunoglobulin G antibody to Pullularia | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747993 | Immunoglobulin G antibody to Pullularia | Full form of descriptor (FN) | NO | |
| RxCUI: 2747993 | Immunoglobulin G antibody to Pullularia | Designated preferred name (PT) | NO | |
| RxCUI: 2747994 | Anti-Helminthosporium IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747994 | Anti-Helminthosporium IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747994 | Anti-Helminthosporium IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747994 | Anti-Helminthosporium IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747995 | Anti-Urtica dioica IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747995 | Anti-Urtica dioica IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747995 | Anti-Urtica dioica IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747995 | Anti-Urtica dioica IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747995 | Anti-Urtica dioica IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747996 | Cucumis melo var. inodorus IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747996 | Cucumis melo var. inodorus IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747996 | Cucumis melo var. inodorus IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747996 | Cucumis melo var. inodorus IgE | Designated preferred name (PT) | NO | |
| RxCUI: 2747996 | Cucumis melo var. inodorus IgE | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747996 | Cucumis melo var. inodorus IgE | Full form of descriptor (FN) | NO | |
| RxCUI: 2747997 | Immunoglobulin E antibody specific to recombinant Sesamum indicum seed i 1 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747997 | Immunoglobulin E antibody specific to recombinant Sesamum indicum seed i 1 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747997 | Immunoglobulin E antibody specific to recombinant Sesamum indicum seed i 1 protein | Full form of descriptor (FN) | NO | |
| RxCUI: 2747997 | Immunoglobulin E antibody specific to recombinant Sesamum indicum seed i 1 protein | Designated preferred name (PT) | NO | |
| RxCUI: 2747997 | Immunoglobulin E antibody specific to recombinant Sesamum indicum seed i 1 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747997 | Immunoglobulin E antibody specific to recombinant Sesamum indicum seed i 1 protein | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747998 | Immunoglobulin G antibody to Morus rubra | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747998 | Immunoglobulin G antibody to Morus rubra | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747998 | Immunoglobulin G antibody to Morus rubra | Full form of descriptor (FN) | NO | |
| RxCUI: 2747998 | Immunoglobulin G antibody to Morus rubra | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747998 | Immunoglobulin G antibody to Morus rubra | Designated preferred name (PT) | NO | |
| RxCUI: 2747999 | Anti-Hypomyces perniciosus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747999 | Anti-Hypomyces perniciosus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2747999 | Anti-Hypomyces perniciosus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2747999 | Anti-Hypomyces perniciosus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2747999 | Anti-Hypomyces perniciosus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748000 | Immunoglobulin G antibody to Rhizopus stolonifer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748000 | Immunoglobulin G antibody to Rhizopus stolonifer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748000 | Immunoglobulin G antibody to Rhizopus stolonifer | Full form of descriptor (FN) | NO | |
| RxCUI: 2748000 | Immunoglobulin G antibody to Rhizopus stolonifer | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748000 | Immunoglobulin G antibody to Rhizopus stolonifer | Designated preferred name (PT) | NO | |
| RxCUI: 2748001 | Immunoglobulin G antibody to Rheum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748001 | Immunoglobulin G antibody to Rheum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748001 | Immunoglobulin G antibody to Rheum | Full form of descriptor (FN) | NO | |
| RxCUI: 2748001 | Immunoglobulin G antibody to Rheum | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748001 | Immunoglobulin G antibody to Rheum | Designated preferred name (PT) | NO | |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748002 | Anti-Amaranthus retroflexus IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2748003 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748003 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi A | Full form of descriptor (FN) | NO | |
| RxCUI: 2748003 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748003 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi A | Designated preferred name (PT) | NO | |
| RxCUI: 2748003 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi A | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748004 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748004 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi B | Full form of descriptor (FN) | NO | |
| RxCUI: 2748004 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748004 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi B | Designated preferred name (PT) | NO | |
| RxCUI: 2748004 | Antigen of Salmonella enterica subspecies enterica serovar Paratyphi B | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748005 | Anti-Medicago sativa IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2748005 | Anti-Medicago sativa IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748005 | Anti-Medicago sativa IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748005 | Anti-Medicago sativa IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2748005 | Anti-Medicago sativa IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748006 | Immunoglobulin G antibody to Serpula lacrimans | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748006 | Immunoglobulin G antibody to Serpula lacrimans | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748006 | Immunoglobulin G antibody to Serpula lacrimans | Full form of descriptor (FN) | NO | |
| RxCUI: 2748006 | Immunoglobulin G antibody to Serpula lacrimans | Designated preferred name (PT) | NO | |
| RxCUI: 2748006 | Immunoglobulin G antibody to Serpula lacrimans | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748007 | Annexin A5 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748007 | Annexin A5 IgG | Designated preferred name (PT) | NO | |
| RxCUI: 2748007 | Annexin A5 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748007 | Annexin A5 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748007 | Annexin A5 IgG | Full form of descriptor (FN) | NO | |
| RxCUI: 2748007 | Annexin A5 IgG | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748008 | 4,5-dibromosalicylanilide | Designated preferred name (PT) | NO | |
| RxCUI: 2748008 | 4,5-dibromosalicylanilide | Full form of descriptor (FN) | NO | |
| RxCUI: 2748009 | Amphotericin B phospholipid complex 5 mg/mL concentrate for dispersion for infusion | Designated preferred name (PT) | NO | |
| RxCUI: 2748009 | Amphotericin B phospholipid complex 5 mg/mL concentrate for dispersion for infusion | Full form of descriptor (FN) | NO | |
| RxCUI: 2748010 | Bromazolam | Designated preferred name (PT) | NO | |
| RxCUI: 2748010 | Bromazolam | Full form of descriptor (FN) | NO | |
| RxCUI: 2748011 | Aprotinin-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748011 | Aprotinin-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748012 | Alfatradiol-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748012 | Alfatradiol-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748013 | 4-hydroxyphenylpyruvate dioxygenase inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748013 | 4-hydroxyphenylpyruvate dioxygenase inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748014 | Menadiol diacetate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748014 | Menadiol diacetate-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748014 | Menadiol diacetate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748015 | Activated attapulgite-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748015 | Activated attapulgite-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748016 | Activated charcoal-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748016 | Activated charcoal-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748017 | Activin A inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748017 | Activin A inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748019 | Adrenergic uptake inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748019 | Adrenergic uptake inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748020 | Azelnidipine-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748020 | Azelnidipine-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748052 | Betula pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748052 | Betula pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 2748052 | Betula pollen | Designated preferred name (PT) | NO | |
| RxCUI: 2748053 | Agrostis capillaris pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748053 | Agrostis capillaris pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 2748053 | Agrostis capillaris pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748053 | Agrostis capillaris pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748053 | Agrostis capillaris pollen | Designated preferred name (PT) | NO | |
| RxCUI: 2748053 | Agrostis capillaris pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748054 | Bromus inermis pollen | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748054 | Bromus inermis pollen | Full form of descriptor (FN) | NO | |
| RxCUI: 2748054 | Bromus inermis pollen | Designated preferred name (PT) | NO | |
| RxCUI: 2748055 | Cetilistat 120 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748055 | Cetilistat 120 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748056 | Brovanexine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748056 | Brovanexine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748057 | Butetamate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748057 | Butetamate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748058 | Camphor-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748058 | Camphor-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748059 | Camphor-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748059 | Camphor-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748060 | Camylofine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748060 | Camylofine-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748060 | Camylofine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748061 | Chondroitin-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748061 | Chondroitin-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748062 | AMPA receptor antagonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748062 | AMPA receptor antagonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748062 | AMPA receptor antagonist-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748062 | AMPA receptor antagonist-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748062 | AMPA receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748062 | AMPA receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748065 | Neonatal Fc (fragment crystallisable) receptor antagonist | British preferred term (PTGB) | NO | |
| RxCUI: 2748065 | Neonatal Fc (fragment crystallisable) receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2748065 | Neonatal Fc (fragment crystallisable) receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2748066 | Neutral buffered formalin 10 percent solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748066 | Neutral buffered formalin 10 percent solution | Full form of descriptor (FN) | NO | |
| RxCUI: 2748066 | Neutral buffered formalin 10 percent solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748066 | Neutral buffered formalin 10 percent solution | Designated preferred name (PT) | NO | |
| RxCUI: 2748069 | Product containing racotumomab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748069 | Product containing racotumomab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748072 | Andusomeran-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748072 | Andusomeran-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748074 | Heparin-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748074 | Heparin-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748079 | Azelnidipine 16 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748079 | Azelnidipine 16 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748080 | Azelnidipine 8 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748080 | Azelnidipine 8 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748081 | Azelnidipine- and metoprolol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748081 | Azelnidipine- and metoprolol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748082 | Balsam of Tolu-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748082 | Balsam of Tolu-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748083 | Avocado oil unsaponifiables-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748083 | Avocado oil unsaponifiables-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748084 | Product containing tyrothricin in vaginal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748084 | Product containing tyrothricin in vaginal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748085 | Azelnidipine 16 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748085 | Azelnidipine 16 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748086 | Azelnidipine 16 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748086 | Azelnidipine 16 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748087 | Product containing tinidazole in vaginal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748087 | Product containing tinidazole in vaginal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748088 | Desidustat 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748088 | Desidustat 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748089 | Product containing thymol in nasal dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748089 | Product containing thymol in nasal dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748090 | Desidustat 50 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748090 | Desidustat 50 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748091 | Product containing zamtocabtagene autoleucel in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748091 | Product containing zamtocabtagene autoleucel in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748092 | Product containing trelagliptin in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748092 | Product containing trelagliptin in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748093 | Product containing tegoprazan in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748093 | Product containing tegoprazan in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748094 | Otilonium-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748094 | Otilonium-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748095 | Betacarotene-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748095 | Betacarotene-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748096 | Arginine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748096 | Arginine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748097 | Azelnidipine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748097 | Azelnidipine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748098 | Benfotiamine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748098 | Benfotiamine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748099 | Cetilistat-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748099 | Cetilistat-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748100 | Colistimethate-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748100 | Colistimethate-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748101 | Diacerein-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748101 | Diacerein-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748102 | Elobixibat-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748102 | Elobixibat-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748103 | Iguratimod-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748103 | Iguratimod-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748104 | Lobeglitazone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748104 | Lobeglitazone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748105 | Menadione-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748105 | Menadione-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748106 | Mifamurtide-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748106 | Mifamurtide-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748107 | Product containing topiroxostat in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748107 | Product containing topiroxostat in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748108 | Magnesium phosphate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748108 | Magnesium phosphate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748109 | Lomifylline-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748109 | Lomifylline-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748110 | Metamizole-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748110 | Metamizole-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748111 | Nitrofural-containing product in vaginal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748111 | Nitrofural-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748111 | Nitrofural-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748112 | Orotic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748112 | Orotic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748113 | Pargeverine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748113 | Pargeverine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748114 | Phenyltoloxamine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748114 | Phenyltoloxamine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748115 | Potassium sulfate-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748115 | Potassium sulfate-containing product in oral dose form | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748115 | Potassium sulfate-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748116 | Product containing rurioctocog alfa in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748116 | Product containing rurioctocog alfa in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748117 | Evogliptin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748117 | Evogliptin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748118 | Dihydrostreptomycin-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748118 | Dihydrostreptomycin-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748119 | Lincomycin-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748119 | Lincomycin-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748120 | Pridinol-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748120 | Pridinol-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748121 | Pargeverine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748121 | Pargeverine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748122 | Betel leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748122 | Betel leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748123 | Product containing quinuclidine (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748123 | Product containing quinuclidine (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2748123 | Product containing quinuclidine (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748123 | Product containing quinuclidine (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2748125 | Mepyramine-containing product in nasal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748125 | Mepyramine-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748125 | Mepyramine-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748126 | Rape leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748126 | Rape leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748128 | Bismuth subsalicylate-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748128 | Bismuth subsalicylate-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748129 | Guaiphenesin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748129 | Guaiphenesin-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748129 | Guaiphenesin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748130 | Iguratimod 25 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748130 | Iguratimod 25 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748132 | Cole leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748132 | Cole leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748133 | Azelnidipine- and metoprolol-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748133 | Azelnidipine- and metoprolol-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748134 | Alpha-tocopherol-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748134 | Alpha-tocopherol-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748135 | Ampicillin- and sulbactam-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748135 | Ampicillin- and sulbactam-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748136 | Bithionol-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748136 | Bithionol-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748137 | Cefalexin-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748137 | Cefalexin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748137 | Cefalexin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748138 | Chlorphenamine-containing product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748138 | Chlorphenamine-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748138 | Chlorphenamine-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748139 | Cellulase-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748139 | Cellulase-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748140 | Citric acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748140 | Citric acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748141 | Cineole-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748141 | Cineole-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748142 | Ergotoxin-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748142 | Ergotoxin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748142 | Ergotoxin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748143 | Eucalyptus oil- and menthol-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748143 | Eucalyptus oil- and menthol-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748144 | Glycosamine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748144 | Glycosamine-containing product in parenteral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748144 | Glycosamine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748145 | Glimepiride- and lobeglitazone-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748145 | Glimepiride- and lobeglitazone-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748146 | Desidustat-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748146 | Desidustat-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748148 | Itopride-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748148 | Itopride-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748149 | Phosphoserine-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748149 | Phosphoserine-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748150 | Polysorbate-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748150 | Polysorbate-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748151 | Product containing vilanterol in pulmonary dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748151 | Product containing vilanterol in pulmonary dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748152 | Amaranth leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748152 | Amaranth leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748153 | Aspirin-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748153 | Aspirin-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748154 | Glycine max isoflavone-containing product in vaginal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748154 | Glycine max isoflavone-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748154 | Glycine max isoflavone-containing product in vaginal dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748154 | Glycine max isoflavone-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748155 | sugammadex Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2748156 | sugammadex 200 MG in 2 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748156 | sugammadex 200 MG in 2 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748156 | sugammadex 200 MG in 2 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748157 | sugammadex 100 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2748158 | sugammadex 500 MG in 5 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748158 | sugammadex 500 MG in 5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748158 | sugammadex 500 MG in 5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748159 | IL-15 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748159 | IL-15 | Designated preferred name (PT) | NO | |
| RxCUI: 2748159 | IL-15 | Full form of descriptor (FN) | NO | |
| RxCUI: 2748160 | IL-21 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748160 | IL-21 | Designated preferred name (PT) | NO | |
| RxCUI: 2748160 | IL-21 | Full form of descriptor (FN) | NO | |
| RxCUI: 2748161 | IL-22 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748161 | IL-22 | Designated preferred name (PT) | NO | |
| RxCUI: 2748161 | IL-22 | Full form of descriptor (FN) | NO | |
| RxCUI: 2748162 | IL-23 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748162 | IL-23 | Designated preferred name (PT) | NO | |
| RxCUI: 2748162 | IL-23 | Full form of descriptor (FN) | NO | |
| RxCUI: 2748163 | IL-27 | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748163 | IL-27 | Designated preferred name (PT) | NO | |
| RxCUI: 2748163 | IL-27 | Full form of descriptor (FN) | NO | |
| RxCUI: 2748164 | Lactic acid-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748164 | Lactic acid-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748165 | Mustard leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748165 | Mustard leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748166 | Messenger ribonucleic acid of Orthopneumovirus hominis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748166 | Messenger ribonucleic acid of Orthopneumovirus hominis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748166 | Messenger ribonucleic acid of Orthopneumovirus hominis | Full form of descriptor (FN) | NO | |
| RxCUI: 2748166 | Messenger ribonucleic acid of Orthopneumovirus hominis | Designated preferred name (PT) | NO | |
| RxCUI: 2748166 | Messenger ribonucleic acid of Orthopneumovirus hominis | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748167 | Patra leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748167 | Patra leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748168 | Taro leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2748168 | Taro leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2748169 | Product containing precisely topiroxostat 20 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748169 | Product containing precisely topiroxostat 20 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2748170 | Product containing precisely topiroxostat 40 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748170 | Product containing precisely topiroxostat 40 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2748171 | Product containing precisely topiroxostat 60 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748171 | Product containing precisely topiroxostat 60 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2748173 | Product containing precisely trelagliptin (as trelagliptin succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748173 | Product containing precisely trelagliptin (as trelagliptin succinate) 100 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2748174 | Product containing precisely trelagliptin (as trelagliptin succinate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748174 | Product containing precisely trelagliptin (as trelagliptin succinate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2748175 | Product containing precisely trelagliptin (as trelagliptin succinate) 50 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748175 | Product containing precisely trelagliptin (as trelagliptin succinate) 50 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2748177 | Trelagliptin succinate | Designated preferred name (PT) | NO | |
| RxCUI: 2748177 | Trelagliptin succinate | Full form of descriptor (FN) | NO | |
| RxCUI: 2748200 | Activin A inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748200 | Activin A inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748201 | Adenosine aminohydrolase inhibitor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748201 | Adenosine aminohydrolase inhibitor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748201 | Adenosine aminohydrolase inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748201 | Adenosine aminohydrolase inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748201 | Adenosine aminohydrolase inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748201 | Adenosine aminohydrolase inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748202 | Adrenergic uptake inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748202 | Adrenergic uptake inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748203 | Aldosterone synthase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748203 | Aldosterone synthase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748206 | A disintegrin and metalloproteinase with thrombospondin motifs 13 Ab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748206 | A disintegrin and metalloproteinase with thrombospondin motifs 13 Ab | Designated preferred name (PT) | NO | |
| RxCUI: 2748206 | A disintegrin and metalloproteinase with thrombospondin motifs 13 Ab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748206 | A disintegrin and metalloproteinase with thrombospondin motifs 13 Ab | Full form of descriptor (FN) | NO | |
| RxCUI: 2748206 | A disintegrin and metalloproteinase with thrombospondin motifs 13 Ab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748207 | Antibody to interferon alpha | Full form of descriptor (FN) | NO | |
| RxCUI: 2748207 | Antibody to interferon alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748207 | Antibody to interferon alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748207 | Antibody to interferon alpha | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748207 | Antibody to interferon alpha | Designated preferred name (PT) | NO | |
| RxCUI: 2748208 | Antibody to interferon gamma | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748208 | Antibody to interferon gamma | Full form of descriptor (FN) | NO | |
| RxCUI: 2748208 | Antibody to interferon gamma | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748208 | Antibody to interferon gamma | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748208 | Antibody to interferon gamma | Designated preferred name (PT) | NO | |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748209 | Anti-asparaginyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748210 | Anti-tyrosyl-tRNA synthetase antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2748211 | Antibody to ribonucleic acid polymerase III subunit 11 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748211 | Antibody to ribonucleic acid polymerase III subunit 11 kilodalton | Full form of descriptor (FN) | NO | |
| RxCUI: 2748211 | Antibody to ribonucleic acid polymerase III subunit 11 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748211 | Antibody to ribonucleic acid polymerase III subunit 11 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748211 | Antibody to ribonucleic acid polymerase III subunit 11 kilodalton | Designated preferred name (PT) | NO | |
| RxCUI: 2748212 | Antibody to ribonucleic acid polymerase III subunit 155 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748212 | Antibody to ribonucleic acid polymerase III subunit 155 kilodalton | Full form of descriptor (FN) | NO | |
| RxCUI: 2748212 | Antibody to ribonucleic acid polymerase III subunit 155 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748212 | Antibody to ribonucleic acid polymerase III subunit 155 kilodalton | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748212 | Antibody to ribonucleic acid polymerase III subunit 155 kilodalton | Designated preferred name (PT) | NO | |
| RxCUI: 2748213 | Antibody to von Willebrand factor collagen binding adhesion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748213 | Antibody to von Willebrand factor collagen binding adhesion | Full form of descriptor (FN) | NO | |
| RxCUI: 2748213 | Antibody to von Willebrand factor collagen binding adhesion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748213 | Antibody to von Willebrand factor collagen binding adhesion | Designated preferred name (PT) | NO | |
| RxCUI: 2748213 | Antibody to von Willebrand factor collagen binding adhesion | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748214 | Alpha-tocopherol-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748214 | Alpha-tocopherol-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748220 | Beta-naphthol-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748220 | Beta-naphthol-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748221 | Collagen-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748221 | Collagen-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748222 | Dequalinium-containing product in vaginal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748222 | Dequalinium-containing product in vaginal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748223 | Diclofenac-containing product in transdermal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748223 | Diclofenac-containing product in transdermal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748224 | Diphenhydramine-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748224 | Diphenhydramine-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748225 | Imeglimin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748225 | Imeglimin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748226 | Lobeglitazone sulfate | Designated preferred name (PT) | NO | |
| RxCUI: 2748226 | Lobeglitazone sulfate | Full form of descriptor (FN) | NO | |
| RxCUI: 2748226 | Lobeglitazone sulfate | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748227 | Lobeglitazone sulfate 500 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2748227 | Lobeglitazone sulfate 500 microgram oral tablet | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748227 | Lobeglitazone sulfate 500 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2748228 | Lorazepam-containing product in oromucosal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748228 | Lorazepam-containing product in oromucosal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748229 | Lung surfactant-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748229 | Lung surfactant-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748230 | L-arterenol bitartrate monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748230 | L-arterenol bitartrate monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748230 | L-arterenol bitartrate monohydrate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748230 | L-arterenol bitartrate monohydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2748230 | L-arterenol bitartrate monohydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2748232 | Pamidronic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748232 | Pamidronic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748233 | Nilotinib hydrochloride dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2748233 | Nilotinib hydrochloride dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2748234 | Butoxyethyl nicotinate- and nonivamide-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748234 | Butoxyethyl nicotinate- and nonivamide-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748234 | Butoxyethyl nicotinate- and nonivamide-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748235 | Neprilysin inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748235 | Neprilysin inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748235 | Neprilysin inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748235 | Neprilysin inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748237 | ApoC-III (apolipoprotein C-III) synthesis inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748237 | ApoC-III (apolipoprotein C-III) synthesis inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748237 | ApoC-III (apolipoprotein C-III) synthesis inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748237 | ApoC-III (apolipoprotein C-III) synthesis inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748237 | ApoC-III (apolipoprotein C-III) synthesis inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748239 | Arachidonate 5-lipoxygenase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748239 | Arachidonate 5-lipoxygenase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748239 | Arachidonate 5-lipoxygenase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748239 | Arachidonate 5-lipoxygenase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748241 | Asterotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2748241 | Asterotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2748241 | Asterotoxin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748243 | Sophora alopecuroides whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2748244 | Ribonucleic acid polymerase III antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2748244 | Ribonucleic acid polymerase III antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2748244 | Ribonucleic acid polymerase III antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748245 | Chromium chloride-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748245 | Chromium chloride-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748246 | Hyaluronic acid-containing product in intravesical dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748246 | Hyaluronic acid-containing product in intravesical dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748247 | Lapirium chloride-containing product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748247 | Lapirium chloride-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748247 | Lapirium chloride-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748251 | Pinaverium bromide-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748251 | Pinaverium bromide-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748252 | Triiodothyronine-containing product in cutaneous dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748252 | Triiodothyronine-containing product in cutaneous dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748252 | Triiodothyronine-containing product in cutaneous dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748253 | Magnesium fluoride-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748253 | Magnesium fluoride-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748254 | Product containing relatlimab in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748254 | Product containing relatlimab in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748255 | Neomycin-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748255 | Neomycin-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748256 | Product containing sodium carbonate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748256 | Product containing sodium carbonate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748257 | Product containing sodium carbonate in otic dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2748257 | Product containing sodium carbonate in otic dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2748258 | Deoxycholic acid-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2748258 | Deoxycholic acid-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2748283 | zidesamtinib | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2748284 | zidesamtinib 100 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2748285 | zidesamtinib Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2748286 | zidesamtinib Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2748287 | zidesamtinib Oral Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2748288 | zidesamtinib 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748288 | zidesamtinib 100 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748289 | Jideytro | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2748290 | zidesamtinib 100 MG [Jideytro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2748291 | Jideytro Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2748292 | Jideytro Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2748293 | zidesamtinib Oral Tablet [Jideytro] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2748294 | Jideytro 100 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748294 | Jideytro 100 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748294 | Jideytro 100 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2748295 | zidesamtinib 25 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2748296 | zidesamtinib 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748296 | zidesamtinib 25 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748297 | zidesamtinib 25 MG [Jideytro] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2748298 | Jideytro 25 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748298 | Jideytro 25 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748298 | Jideytro 25 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2748299 | Complement inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748299 | Complement inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748299 | Complement inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748299 | Complement inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748301 | Cytidine deaminase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748301 | Cytidine deaminase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748301 | Cytidine deaminase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748301 | Cytidine deaminase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748303 | Cytochrome P450 2C19 inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748303 | Cytochrome P450 2C19 inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748303 | Cytochrome P450 2C19 inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748303 | Cytochrome P450 2C19 inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748306 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748306 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748306 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748306 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2748306 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748306 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2748308 | Dehydrogenase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748308 | Dehydrogenase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748308 | Dehydrogenase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748308 | Dehydrogenase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748315 | HIF hydroxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748315 | HIF hydroxylase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748315 | HIF hydroxylase inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748315 | HIF hydroxylase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2748315 | HIF hydroxylase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2748315 | HIF hydroxylase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 27484 | Impromidine | Designated preferred name (PT) | NO | |
| RxCUI: 27484 | Impromidine | Full form of descriptor (FN) | NO | |
| RxCUI: 27484 | Impromidine | Designated preferred name (PT) | NO | |
| RxCUI: 27484 | Impromidine | Full form of descriptor (FN) | NO | |
| RxCUI: 2748447 | insulin aspart-fsan | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2748448 | insulin aspart-fsan 100 UNT/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2748451 | insulin aspart-fsan 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748451 | insulin aspart-fsan 100 UNT/ML Injectable Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748452 | Garzulys | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2748453 | insulin aspart-fsan 100 UNT/ML [Garzulys] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2748454 | Garzulys Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2748455 | insulin aspart, human Injectable Solution [Garzulys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2748457 | Garzulys 100 UNT/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748457 | Garzulys 100 UNT/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748457 | Garzulys 100 UNT/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2748459 | insulin aspart-fsan 100 UNT/ML in 3 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748459 | insulin aspart-fsan 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748459 | insulin aspart-fsan 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748460 | insulin aspart-fsan 100 UNT/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2748460 | insulin aspart-fsan 100 UNT/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2748461 | insulin aspart, human Pen Injector [Garzulys] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2748463 | Garzulys 100 UNT/ML in 3 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2748463 | Garzulys 100 UNT/ML in 3 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748463 | Garzulys 100 UNT/ML in 3 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748464 | Garzulys 100 UNT/ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2748464 | Garzulys 100 UNT/ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748464 | Garzulys 100 UNT/ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2748465 | Euphorbia esula whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2748466 | Lycopus lucidus var. hirtus flowering top extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2748467 | amlodipine Chewable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2748467 | amlodipine Chewable Product | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748468 | amlodipine Chewable Tablet | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2748468 | amlodipine Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748469 | amLODIPine 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748469 | amLODIPine 1.25 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748469 | amLODIPine 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2748469 | amLODIPine 1.25 MG Chewable Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2748469 | amLODIPine 1.25 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748470 | Amodip | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2748471 | amlodipine 1.25 MG [Amodip] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2748471 | amlodipine 1.25 MG [Amodip] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748472 | Amodip Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2748473 | Amodip Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2748474 | Amodip Chewable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2748475 | amlodipine Chewable Tablet [Amodip] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2748475 | amlodipine Chewable Tablet [Amodip] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748476 | AMODIP 1.25 MG Chewable Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2748476 | AMODIP 1.25 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748476 | AMODIP 1.25 MG Chewable Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748476 | AMODIP 1.25 MG Chewable Tablet | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2748476 | AMODIP 1.25 MG Chewable Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2748479 | camphor 0.2 % Topical Oil | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2748479 | camphor 0.2 % Topical Oil | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748479 | camphor 0.2 % Topical Oil | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2748662 | ropeginterferon alfa-2b-njft 1 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2748663 | ropeginterferon alfa-2b Pen Injector | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2748665 | ropeginterferon alfa-2b-njft 500 MCG in 0.5 ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2748665 | ropeginterferon alfa-2b-njft 500 MCG in 0.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748665 | ropeginterferon alfa-2b-njft 500 MCG in 0.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748666 | ropeginterferon alfa-2b-njft 1 MG/ML Pen Injector | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2748667 | ropeginterferon alfa-2b-njft 1 MG/ML [Besremi] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2748668 | ropeginterferon alfa-2b Pen Injector [Besremi] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2748670 | BESREMi 500 MCG in 0.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748670 | BESREMi 500 MCG in 0.5 ML Pen Injector | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2748670 | BESREMi 500 MCG in 0.5 ML Pen Injector | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2748670 | BESREMi 500 MCG in 0.5 ML Pen Injector | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2748671 | ropeginterferon alfa-2b-njft 1 MG/ML Pen Injector [Besremi] | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2748671 | ropeginterferon alfa-2b-njft 1 MG/ML Pen Injector [Besremi] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749 | Complement, thermolabile serum protein complex with cytotoxic effect | Designated preferred name (PT) | NO | |
| RxCUI: 2749 | Complement, thermolabile serum protein complex with cytotoxic effect | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749 | Complement, thermolabile serum protein complex with cytotoxic effect | Full form of descriptor (FN) | NO | |
| RxCUI: 2749054 | Imeglimin hydrochloride 1 g oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2749054 | Imeglimin hydrochloride 1 g oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2749055 | Imeglimin hydrochloride 500 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2749055 | Imeglimin hydrochloride 500 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2749056 | Messenger ribonucleic acid of influenza virus | Designated preferred name (PT) | NO | |
| RxCUI: 2749056 | Messenger ribonucleic acid of influenza virus | Designated preferred name (PT) | NO | |
| RxCUI: 2749056 | Messenger ribonucleic acid of influenza virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749056 | Messenger ribonucleic acid of influenza virus | Full form of descriptor (FN) | NO | |
| RxCUI: 2749056 | Messenger ribonucleic acid of influenza virus | Full form of descriptor (FN) | NO | |
| RxCUI: 2749058 | Antibody to interferon omega | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749058 | Antibody to interferon omega | Full form of descriptor (FN) | NO | |
| RxCUI: 2749058 | Antibody to interferon omega | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749058 | Antibody to interferon omega | Designated preferred name (PT) | NO | |
| RxCUI: 2749061 | Interferon omega Ab | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Full form of descriptor (FN) | NO | |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Designated preferred name (PT) | NO | |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749063 | Anti-phenylalanyl-tRNA synthetase antibody | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749069 | sodium hyaluronate 10 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749070 | hyaluronate Vaginal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749071 | hyaluronate Vaginal Insert | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749074 | hyaluronate sodium 10 MG Vaginal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749074 | hyaluronate sodium 10 MG Vaginal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749074 | hyaluronate sodium 10 MG Vaginal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749075 | sodium hyaluronate 5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749076 | hyaluronate sodium 5 MG Vaginal Suppository | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749076 | hyaluronate sodium 5 MG Vaginal Suppository | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749076 | hyaluronate sodium 5 MG Vaginal Suppository | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749092 | gentiopicrin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749093 | aflibercept-jbvf | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749094 | aflibercept-jbvf 40 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749097 | aflibercept-jbvf 2 MG in 0.05 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749097 | aflibercept-jbvf 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749097 | aflibercept-jbvf 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749098 | aflibercept-jbvf 40 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749098 | aflibercept-jbvf 40 MG/ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749099 | Yesafili | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749100 | aflibercept-jbvf 40 MG/ML [Yesafili] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749101 | Yesafili Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749102 | aflibercept Prefilled Syringe [Yesafili] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749104 | Yesafili 2 MG in 0.05 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749104 | Yesafili 2 MG in 0.05 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749104 | Yesafili 2 MG in 0.05 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749105 | Yesafili 40 MG/ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749105 | Yesafili 40 MG/ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749105 | Yesafili 40 MG/ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749106 | bevacizumab-vikg | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749107 | bevacizumab-vikg 25 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749110 | bevacizumab-vikg 1.25 MG in 0.05 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749110 | bevacizumab-vikg 1.25 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749110 | bevacizumab-vikg 1.25 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749111 | bevacizumab-vikg 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749111 | bevacizumab-vikg 25 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749112 | Lytenava | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749113 | bevacizumab-vikg 25 MG/ML [Lytenava] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749114 | Lytenava Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749115 | bevacizumab Injection [Lytenava] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749117 | LYTENAVA 1.25 MG in 0.05 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749117 | LYTENAVA 1.25 MG in 0.05 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749117 | LYTENAVA 1.25 MG in 0.05 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749118 | LYTENAVA 25 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749118 | LYTENAVA 25 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749118 | LYTENAVA 25 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749119 | diazePAM 20 MG in 4 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749119 | diazePAM 20 MG in 4 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2749119 | diazePAM 20 MG in 4 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749119 | diazePAM 20 MG in 4 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749119 | diazePAM 20 MG in 4 ML Prefilled Syringe | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | YES |
| RxCUI: 2749120 | menthol 12.5 % Topical Gel | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749120 | menthol 12.5 % Topical Gel | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749120 | menthol 12.5 % Topical Gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749121 | salicylic acid 0.007 MG/MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2749122 | salicylic acid 0.7 % Medicated Patch | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749122 | salicylic acid 0.7 % Medicated Patch | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749122 | salicylic acid 0.7 % Medicated Patch | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749123 | 3,5-dibromosalicylanilide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749123 | 3,5-dibromosalicylanilide | Designated preferred name (PT) | NO | |
| RxCUI: 2749123 | 3,5-dibromosalicylanilide | Full form of descriptor (FN) | NO | |
| RxCUI: 2749125 | 4',5-dibromosalicylanilide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749125 | 4',5-dibromosalicylanilide | Designated preferred name (PT) | NO | |
| RxCUI: 2749125 | 4',5-dibromosalicylanilide | Full form of descriptor (FN) | NO | |
| RxCUI: 2749128 | Aescin-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749129 | Aesculin-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749129 | Aesculin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749129 | Aesculin-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749129 | Aesculin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749137 | Colestilan chloride-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749137 | Colestilan chloride-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749139 | Colestilan-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749140 | Benzoxazine | Designated preferred name (PT) | NO | |
| RxCUI: 2749140 | Benzoxazine | Full form of descriptor (FN) | NO | |
| RxCUI: 2749140 | Benzoxazine | Designated preferred name (PT) | NO | |
| RxCUI: 2749140 | Benzoxazine | Full form of descriptor (FN) | NO | |
| RxCUI: 2749143 | Edotreotide only product | Designated preferred name (PT) | NO | |
| RxCUI: 2749143 | Edotreotide only product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749149 | Benzopyran | Designated preferred name (PT) | NO | |
| RxCUI: 2749149 | Benzopyran | Full form of descriptor (FN) | NO | |
| RxCUI: 2749149 | Benzopyran | Designated preferred name (PT) | NO | |
| RxCUI: 2749149 | Benzopyran | Full form of descriptor (FN) | NO | |
| RxCUI: 2749153 | Diarylmethane | Designated preferred name (PT) | NO | |
| RxCUI: 2749153 | Diarylmethane | Full form of descriptor (FN) | NO | |
| RxCUI: 2749153 | Diarylmethane | Designated preferred name (PT) | NO | |
| RxCUI: 2749153 | Diarylmethane | Full form of descriptor (FN) | NO | |
| RxCUI: 2749160 | Product containing tanruprubart (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749160 | Product containing tanruprubart (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2749160 | Product containing tanruprubart (medicinal product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749160 | Product containing tanruprubart (medicinal product) | Designated preferred name (PT) | NO | |
| RxCUI: 2749163 | Product containing precisely tegoprazan 50 milligram/1 each conventional release oral tablet (clinical drug) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749163 | Product containing precisely tegoprazan 50 milligram/1 each conventional release oral tablet (clinical drug) | Designated preferred name (PT) | NO | |
| RxCUI: 2749166 | beclomethasone dipropionate 0.172 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749167 | formoterol fumarate 0.0049 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749168 | glycopyrrolate 0.0106 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749171 | beclomethasone dipropionate 0.172 MG/ACTUAT / formoterol fumarate 0.0049 MG/ACTUAT / glycopyrrolate 0.0106 MG/ACTUAT [Trimbow] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749175 | beclomethasone dipropionate 0.086 MG/ACTUAT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749178 | beclomethasone dipropionate 0.086 MG/ACTUAT / formoterol fumarate 0.0049 MG/ACTUAT / glycopyrrolate 0.0106 MG/ACTUAT [Trimbow] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 27492 | indanazoline | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749251 | Fluarix 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749252 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML [Fluarix 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749253 | Fluarix 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749254 | influenza A virus (H1N1) antigen / influenza A virus (H3N2) antigen / influenza B virus antigen Prefilled Syringe [Fluarix 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749256 | FLUARIX 2026-2027 vaccine 0.5 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749256 | FLUARIX 2026-2027 vaccine 0.5 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749256 | FLUARIX 2026-2027 vaccine 0.5 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749257 | influenza A virus A/Michigan/105/2025 (H3N2) antigen 0.03 MG/ML / influenza A virus A/Switzerland/6849/2025 (H1N1) antigen 0.03 MG/ML / influenza B virus B/Tokyo/EIS13-175/2025 antigen 0.03 MG/ML Prefilled Syringe [Fluarix 2026-2027] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749264 | Copaifera officinalis resin oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2749265 | Dendrobium officinale whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749266 | undecylenic acid 15 % / zinc undecylenate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749266 | undecylenic acid 15 % / zinc undecylenate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749266 | undecylenic acid 15 % / zinc undecylenate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749267 | epinephrine / lidocaine Rectal Foam | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2749267 | epinephrine / lidocaine Rectal Foam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749268 | epinephrine hydrochloride / lidocaine hydrochloride Rectal Foam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749269 | EPINEPHrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Foam | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749269 | EPINEPHrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Foam | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749269 | EPINEPHrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Foam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749269 | EPINEPHrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Foam | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749269 | EPINEPHrine hydrochloride 0.01 % / lidocaine hydrochloride 5 % Rectal Foam | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749270 | dimethyl imidazolidinone | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749292 | Aluminium hydroxide magnesium carbonate co-dried gel | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749292 | Aluminium hydroxide magnesium carbonate co-dried gel | Full form of descriptor (FN) | NO | |
| RxCUI: 2749292 | Aluminium hydroxide magnesium carbonate co-dried gel | Designated preferred name (PT) | NO | |
| RxCUI: 2749294 | Avena fatua pollen extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749294 | Avena fatua pollen extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749297 | Azithromycin monohydrate isopropanolate | Designated preferred name (PT) | NO | |
| RxCUI: 2749297 | Azithromycin monohydrate isopropanolate | Full form of descriptor (FN) | NO | |
| RxCUI: 2749298 | Peumus boldus dry extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749298 | Peumus boldus dry extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749298 | Peumus boldus dry extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749300 | Bonellin | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749300 | Bonellin | Designated preferred name (PT) | NO | |
| RxCUI: 2749300 | Bonellin | Full form of descriptor (FN) | NO | |
| RxCUI: 2749302 | Cilantro | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749302 | Cilantro | Designated preferred name (PT) | NO | |
| RxCUI: 2749302 | Cilantro | Full form of descriptor (FN) | NO | |
| RxCUI: 2749304 | Citrus bioflavonoid extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749304 | Citrus bioflavonoid extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749309 | influenza vaccine, mRNA, A/Michigan/105/2025 (H3N2) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749310 | influenza vaccine, mRNA hemagglutinin glycoprotein | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2749311 | influenza vaccine, mRNA, A/Michigan/105/2025 (H3N2) 0.0329 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749312 | influenza vaccine, mRNA, A/Missouri/11/2025 (H1N1) | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749313 | influenza vaccine, mRNA, A/Missouri/11/2025 (H1N1) 0.0329 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749314 | influenza vaccine, mRNA, B/Pennsylvania/19/2025 | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749315 | influenza vaccine, mRNA, B/Pennsylvania/19/2025 0.0329 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749316 | influenza vaccine, mRNA hemagglutinin glycoprotein Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749317 | influenza vaccine, mRNA hemagglutinin glycoprotein Prefilled Syringe | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749320 | influenza vaccine, mRNA 2026-2027 (trivalent - Michigan/Missouri/Pennsylvania) 0.38 ML Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749320 | influenza vaccine, mRNA 2026-2027 (trivalent - Michigan/Missouri/Pennsylvania) 0.38 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749320 | influenza vaccine, mRNA 2026-2027 (trivalent - Michigan/Missouri/Pennsylvania) 0.38 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749321 | influenza vaccine, mRNA 2026-2027 (trivalent - Michigan/Missouri/Pennsylvania) Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749321 | influenza vaccine, mRNA 2026-2027 (trivalent - Michigan/Missouri/Pennsylvania) Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749321 | influenza vaccine, mRNA 2026-2027 (trivalent - Michigan/Missouri/Pennsylvania) Prefilled Syringe | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749322 | Mflusiva 2026-2027 | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749323 | influenza vaccine, mRNA, A/Michigan/105/2025 (H3N2) 0.0329 MG/ML / influenza vaccine, mRNA, A/Missouri/11/2025 (H1N1) 0.0329 MG/ML / influenza vaccine, mRNA, B/Pennsylvania/19/2025 0.0329 MG/ML [Mflusiva 2026-2027] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749324 | Mflusiva 2026-2027 Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749325 | influenza vaccine, mRNA hemagglutinin glycoprotein Prefilled Syringe [Mflusiva 2026-2027] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749327 | mFLUSIVA 2026-2027 mRNA vaccine 0.38 ML Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749327 | mFLUSIVA 2026-2027 mRNA vaccine 0.38 ML Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749327 | mFLUSIVA 2026-2027 mRNA vaccine 0.38 ML Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749328 | mFLUSIVA 2026-2027 mRNA vaccine Prefilled Syringe | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749328 | mFLUSIVA 2026-2027 mRNA vaccine Prefilled Syringe | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749328 | mFLUSIVA 2026-2027 mRNA vaccine Prefilled Syringe | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749384 | Your Choice | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749385 | levonorgestrel 1.5 MG [Your Choice] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749386 | Your Choice Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749387 | Your Choice Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749388 | levonorgestrel Oral Tablet [Your Choice] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749389 | YOUR CHOICE 1.5 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749389 | YOUR CHOICE 1.5 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749389 | YOUR CHOICE 1.5 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 27494 | Indanol dehydrogenase | Designated preferred name (PT) | NO | |
| RxCUI: 27494 | Indanol dehydrogenase | Full form of descriptor (FN) | NO | |
| RxCUI: 2749403 | acetaminophen 325 MG / naproxen sodium 110 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749403 | acetaminophen 325 MG / naproxen sodium 110 MG Oral Tablet | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749403 | acetaminophen 325 MG / naproxen sodium 110 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749407 | bis-PEG-10 dimethicone (300 MPA.S) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2749408 | Cyperus scariosus root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749409 | Hibiscus abelmoschus seed oil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749410 | undecylenic acid 300 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2749411 | undecylenic acid 30 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749411 | undecylenic acid 30 % Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749411 | undecylenic acid 30 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749412 | methyl salicylate 14 % / menthol 4 % / camphor 4 % Topical Ointment | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749412 | methyl salicylate 14 % / menthol 4 % / camphor 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749412 | methyl salicylate 14 % / menthol 4 % / camphor 4 % Topical Ointment | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749412 | methyl salicylate 14 % / menthol 4 % / camphor 4 % Topical Ointment | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749414 | acellular nerve allograft-arwx | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749415 | acellular nerve allograft | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2749416 | acellular nerve allograft-arwx 1 UNT | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749417 | acellular nerve allograft Drug Implant Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749418 | acellular nerve allograft Drug Implant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749421 | acellular nerve allograft-arwx Implant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749421 | acellular nerve allograft-arwx Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749421 | acellular nerve allograft-arwx Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749422 | Avance | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749423 | acellular nerve allograft-arwx 1 UNT [Avance] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749424 | Avance Drug Implant Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749425 | acellular nerve allograft Drug Implant [Avance] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749427 | Avance Nerve Allograft Implant | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749427 | Avance Nerve Allograft Implant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749427 | Avance Nerve Allograft Implant | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749428 | ethinyl estradiol 0.000833 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749429 | norelgestromin 0.00917 MG/HR | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749430 | norelgestromin 220 MCG / ethinyl estradiol 20 MCG per Day Weekly Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749430 | norelgestromin 220 MCG / ethinyl estradiol 20 MCG per Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749430 | norelgestromin 220 MCG / ethinyl estradiol 20 MCG per Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749430 | norelgestromin 220 MCG / ethinyl estradiol 20 MCG per Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749431 | ethinyl estradiol 0.000833 MG/HR / norelgestromin 0.00917 MG/HR Transdermal System | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749432 | Gwyn Lo | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749433 | ethinyl estradiol 0.000833 MG/HR / norelgestromin 0.00917 MG/HR [Gwyn Lo] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749434 | Gwyn Lo Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749435 | Gwyn Lo Transdermal Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749436 | ethinyl estradiol / norelgestromin Transdermal System [Gwyn Lo] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749437 | Gwyn Lo 220 MCG/20 MCG per Day Weekly Transdermal System | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749437 | Gwyn Lo 220 MCG/20 MCG per Day Weekly Transdermal System | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749437 | Gwyn Lo 220 MCG/20 MCG per Day Weekly Transdermal System | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749438 | ethinyl estradiol 0.000833 MG/HR / norelgestromin 0.00917 MG/HR Transdermal System [Gwyn Lo] | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749443 | Evernic acid | Designated preferred name (PT) | NO | |
| RxCUI: 2749443 | Evernic acid | Full form of descriptor (FN) | NO | |
| RxCUI: 2749444 | Glimepiride 1 mg and lobeglitazone sulfate 500 microgram oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2749444 | Glimepiride 1 mg and lobeglitazone sulfate 500 microgram oral tablet | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749444 | Glimepiride 1 mg and lobeglitazone sulfate 500 microgram oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2749445 | Imeglimin hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 2749445 | Imeglimin hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 2749447 | Prothionamide 125 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2749447 | Prothionamide 125 mg oral tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749447 | Prothionamide 125 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2749450 | Insulin aspart protamine-containing product in parenteral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749450 | Insulin aspart protamine-containing product in parenteral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749451 | Escin-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749451 | Escin-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749452 | Product containing sodium sulfate in oral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749452 | Product containing sodium sulfate in oral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2749452 | Product containing sodium sulfate in oral dose form (medicinal product form) | British synonym (SYGB) | British synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749453 | Levofloxacin-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749453 | Levofloxacin-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749454 | Product containing recombinant interleukin 2 in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749454 | Product containing recombinant interleukin 2 in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2749456 | Pulmonary surfactant-containing product in pulmonary dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749457 | Glycine-containing product in urethral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749457 | Glycine-containing product in urethral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749476 | Bosutinib dihydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2749476 | Bosutinib dihydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2749477 | Wolfiporia cocos extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749477 | Wolfiporia cocos extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749477 | Wolfiporia cocos extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749479 | Colony stimulating factor 1 receptor inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749479 | Colony stimulating factor 1 receptor inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749479 | Colony stimulating factor 1 receptor inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749479 | Colony stimulating factor 1 receptor inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749479 | Colony stimulating factor 1 receptor inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749482 | Complement 5a receptor inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749482 | Complement 5a receptor inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749482 | Complement 5a receptor inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749482 | Complement 5a receptor inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749482 | Complement 5a receptor inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749482 | Complement 5a receptor inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749486 | Bromus inermis pollen extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749486 | Bromus inermis pollen extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749487 | Conotoxin | Designated preferred name (PT) | NO | |
| RxCUI: 2749487 | Conotoxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2749488 | Insulin-like growth factor-1 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749488 | Insulin-like growth factor-1 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749488 | Insulin-like growth factor-1 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749488 | Insulin-like growth factor-1 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749490 | Foxtail bristlegrass extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749490 | Foxtail bristlegrass extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749490 | Foxtail bristlegrass extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749490 | Foxtail bristlegrass extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749490 | Foxtail bristlegrass extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749490 | Foxtail bristlegrass extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749496 | Lenalidomide hydrochloride hydrate | Designated preferred name (PT) | NO | |
| RxCUI: 2749496 | Lenalidomide hydrochloride hydrate | Full form of descriptor (FN) | NO | |
| RxCUI: 2749497 | Olea europaea pollen extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749497 | Olea europaea pollen extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749497 | Olea europaea pollen extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749499 | Messenger ribonucleic acid of virus | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749499 | Messenger ribonucleic acid of virus | Full form of descriptor (FN) | NO | |
| RxCUI: 2749499 | Messenger ribonucleic acid of virus | Full form of descriptor (FN) | NO | |
| RxCUI: 2749499 | Messenger ribonucleic acid of virus | Designated preferred name (PT) | NO | |
| RxCUI: 2749499 | Messenger ribonucleic acid of virus | Designated preferred name (PT) | NO | |
| RxCUI: 2749501 | Drumstick leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2749501 | Drumstick leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2749502 | Curry leaf | Designated preferred name (PT) | NO | |
| RxCUI: 2749502 | Curry leaf | Full form of descriptor (FN) | NO | |
| RxCUI: 2749503 | Tilia dry extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749503 | Tilia dry extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749503 | Tilia dry extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749505 | Elobixibat 5 mg oral tablet | Designated preferred name (PT) | NO | |
| RxCUI: 2749505 | Elobixibat 5 mg oral tablet | Full form of descriptor (FN) | NO | |
| RxCUI: 2749506 | Growth hormone receptor agonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749506 | Growth hormone receptor agonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749506 | Growth hormone receptor agonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749506 | Growth hormone receptor agonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749508 | Sisymbrium officinale dry extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749508 | Sisymbrium officinale dry extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749508 | Sisymbrium officinale dry extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749510 | Formol sublimate | Designated preferred name (PT) | NO | |
| RxCUI: 2749510 | Formol sublimate | Full form of descriptor (FN) | NO | |
| RxCUI: 2749511 | Carbon dioxide only product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2749511 | Carbon dioxide only product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2749512 | Inula britannica extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749512 | Inula britannica extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749512 | Inula britannica extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749514 | Crataegus monogyna extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749514 | Crataegus monogyna extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749514 | Crataegus monogyna extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749514 | Crataegus monogyna extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749514 | Crataegus monogyna extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749514 | Crataegus monogyna extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749520 | Ziziphus jujuba extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749520 | Ziziphus jujuba extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749520 | Ziziphus jujuba extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749522 | Formosa sweet gum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749522 | Formosa sweet gum extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749522 | Formosa sweet gum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749522 | Formosa sweet gum extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749525 | Glutathione transferase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749525 | Glutathione transferase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749525 | Glutathione transferase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749525 | Glutathione transferase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749529 | Hydrocortisone-containing product in nasal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749529 | Hydrocortisone-containing product in nasal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749530 | Insulin efsitora alfa-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749530 | Insulin efsitora alfa-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749531 | Air- and carbon dioxide-containing product in gas for inhalation | Designated preferred name (PT) | NO | |
| RxCUI: 2749531 | Air- and carbon dioxide-containing product in gas for inhalation | Full form of descriptor (FN) | NO | |
| RxCUI: 2749532 | Arachis oil extract of coal tar | Designated preferred name (PT) | NO | |
| RxCUI: 2749532 | Arachis oil extract of coal tar | Full form of descriptor (FN) | NO | |
| RxCUI: 2749533 | Cetomacrogol emulsifying wax | Designated preferred name (PT) | NO | |
| RxCUI: 2749533 | Cetomacrogol emulsifying wax | Full form of descriptor (FN) | NO | |
| RxCUI: 2749534 | Product containing retinol in cutaneous dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749534 | Product containing retinol in cutaneous dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2749535 | Phenylephrine-containing product in pulmonary dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749535 | Phenylephrine-containing product in pulmonary dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749536 | Phenol-containing product in oropharyngeal dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749536 | Phenol-containing product in oropharyngeal dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749537 | Glycine max unsaponifiables-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749537 | Glycine max unsaponifiables-containing product in oral dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749537 | Glycine max unsaponifiables-containing product in oral dose form | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749537 | Glycine max unsaponifiables-containing product in oral dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749540 | Inosine-containing product in ocular dose form | Designated preferred name (PT) | NO | |
| RxCUI: 2749540 | Inosine-containing product in ocular dose form | Full form of descriptor (FN) | NO | |
| RxCUI: 2749541 | Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749541 | Product containing trastuzumab emtansine in parenteral dose form (medicinal product form) | Designated preferred name (PT) | NO | |
| RxCUI: 2749542 | Meloxicam- and pridinol-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749542 | Meloxicam- and pridinol-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749544 | Helly fixative | Designated preferred name (PT) | NO | |
| RxCUI: 2749544 | Helly fixative | Full form of descriptor (FN) | NO | |
| RxCUI: 2749545 | Epimedium sagittatum extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749545 | Epimedium sagittatum extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749546 | Lavandula flower | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749546 | Lavandula flower | Full form of descriptor (FN) | NO | |
| RxCUI: 2749546 | Lavandula flower | Designated preferred name (PT) | NO | |
| RxCUI: 2749548 | Tissue fixative | Designated preferred name (PT) | NO | |
| RxCUI: 2749548 | Tissue fixative | Full form of descriptor (FN) | NO | |
| RxCUI: 2749549 | Zenker fixative | Designated preferred name (PT) | NO | |
| RxCUI: 2749549 | Zenker fixative | Full form of descriptor (FN) | NO | |
| RxCUI: 2749552 | Carnoy fixative | Designated preferred name (PT) | NO | |
| RxCUI: 2749552 | Carnoy fixative | Full form of descriptor (FN) | NO | |
| RxCUI: 2749553 | Polygonatum sibiricum extract | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749553 | Polygonatum sibiricum extract | Full form of descriptor (FN) | NO | |
| RxCUI: 2749553 | Polygonatum sibiricum extract | Designated preferred name (PT) | NO | |
| RxCUI: 2749559 | Rho kinase (ROCK) inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749559 | Rho kinase (ROCK) inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749559 | Rho kinase (ROCK) inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749561 | IBAT (ileal bile acid transporter) inhibitor | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749561 | IBAT (ileal bile acid transporter) inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749561 | IBAT (ileal bile acid transporter) inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749563 | Mitogen-activated protein kinase kinase inhibitor | Designated preferred name (PT) | NO | |
| RxCUI: 2749563 | Mitogen-activated protein kinase kinase inhibitor | Full form of descriptor (FN) | NO | |
| RxCUI: 2749564 | IBAT (ileal bile acid transporter) inhibitor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749564 | IBAT (ileal bile acid transporter) inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749564 | IBAT (ileal bile acid transporter) inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749566 | Mesenchymal epithelial transition inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749566 | Mesenchymal epithelial transition inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749567 | NAD(P)H dehydrogenase (quinone) inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749567 | NAD(P)H dehydrogenase (quinone) inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749568 | Mitogen-activated protein kinase kinase inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749568 | Mitogen-activated protein kinase kinase inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749569 | Rho kinase (ROCK) inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749569 | Rho kinase (ROCK) inhibitor-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749569 | Rho kinase (ROCK) inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749571 | Product containing Severe acute respiratory syndrome coronavirus main protease inhibitor (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749571 | Product containing Severe acute respiratory syndrome coronavirus main protease inhibitor (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2749572 | Non-chaperonin molecular chaperone ATPase inhibitor-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749572 | Non-chaperonin molecular chaperone ATPase inhibitor-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749573 | Product containing sodium taurocholate cotransporting polypeptide inhibitor (product) | Full form of descriptor (FN) | NO | |
| RxCUI: 2749573 | Product containing sodium taurocholate cotransporting polypeptide inhibitor (product) | Designated preferred name (PT) | NO | |
| RxCUI: 2749574 | Plasmin-alpha-2 plasmin inhibitor complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749574 | Plasmin-alpha-2 plasmin inhibitor complex | Designated preferred name (PT) | NO | |
| RxCUI: 2749574 | Plasmin-alpha-2 plasmin inhibitor complex | Full form of descriptor (FN) | NO | |
| RxCUI: 2749576 | apixaban 0.15 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749577 | apixaban Oral Powder Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749578 | apixaban Powder for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749579 | apixaban 0.15 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749579 | apixaban 0.15 MG Powder for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749580 | apixaban 0.15 MG [Eliquis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749581 | Eliquis Oral Powder Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749582 | apixaban Powder for Oral Suspension [Eliquis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749583 | Eliquis Sprinkle 0.15 MG Powder for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749583 | Eliquis Sprinkle 0.15 MG Powder for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749583 | Eliquis Sprinkle 0.15 MG Powder for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749584 | Autologous tumor infiltrating lymphocyte | Designated preferred name (PT) | NO | |
| RxCUI: 2749584 | Autologous tumor infiltrating lymphocyte | Full form of descriptor (FN) | NO | |
| RxCUI: 2749584 | Autologous tumor infiltrating lymphocyte | British preferred term (PTGB) | NO | |
| RxCUI: 2749585 | Bouin fluid | Designated preferred name (PT) | NO | |
| RxCUI: 2749585 | Bouin fluid | Full form of descriptor (FN) | NO | |
| RxCUI: 2749586 | Fish oil rich in omega-3 acids | Designated preferred name (PT) | NO | |
| RxCUI: 2749586 | Fish oil rich in omega-3 acids | Full form of descriptor (FN) | NO | |
| RxCUI: 2749587 | Ground ginger | Designated preferred name (PT) | NO | |
| RxCUI: 2749587 | Ground ginger | Full form of descriptor (FN) | NO | |
| RxCUI: 2749588 | Interleukin 13 receptor antagonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749588 | Interleukin 13 receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749589 | Interleukin 17 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749589 | Interleukin 17 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749589 | Interleukin 17 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749589 | Interleukin 17 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749591 | Interleukin 6 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749591 | Interleukin 6 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749591 | Interleukin 6 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749591 | Interleukin 6 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749593 | Interleukin-13 receptor antagonist | Designated preferred name (PT) | NO | |
| RxCUI: 2749593 | Interleukin-13 receptor antagonist | Full form of descriptor (FN) | NO | |
| RxCUI: 2749594 | Marine toxin | Designated preferred name (PT) | NO | |
| RxCUI: 2749594 | Marine toxin | Full form of descriptor (FN) | NO | |
| RxCUI: 2749595 | Neonatal fragment crystallizable receptor antagonist-containing product | Designated preferred name (PT) | NO | |
| RxCUI: 2749595 | Neonatal fragment crystallizable receptor antagonist-containing product | Full form of descriptor (FN) | NO | |
| RxCUI: 2749597 | Plasminogen activator tissue type-plasminogen activator inhibitor 1 complex | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749597 | Plasminogen activator tissue type-plasminogen activator inhibitor 1 complex | Designated preferred name (PT) | NO | |
| RxCUI: 2749597 | Plasminogen activator tissue type-plasminogen activator inhibitor 1 complex | Full form of descriptor (FN) | NO | |
| RxCUI: 274961 | Zeatin O-beta-D-xylosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 274961 | Zeatin O-beta-D-xylosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 274964 | Ciclesonide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 274964 | Ciclesonide | Designated preferred name (PT) | YES | |
| RxCUI: 274964 | Ciclesonide | Full form of descriptor (FN) | YES | |
| RxCUI: 274964 | Ciclesonide | Designated preferred name (PT) | YES | |
| RxCUI: 274964 | Ciclesonide | Full form of descriptor (FN) | YES | |
| RxCUI: 2749682 | apixaban 0.5 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749683 | apixaban Oral Liquid Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749684 | apixaban Tablet for Oral Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749685 | apixaban 0.5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749685 | apixaban 0.5 MG Tablet for Oral Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749686 | apixaban 0.5 MG [Eliquis] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749687 | Eliquis Oral Liquid Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749688 | apixaban Tablet for Oral Suspension [Eliquis] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749689 | Eliquis 0.5 MG Tablet for Oral Suspension | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749689 | Eliquis 0.5 MG Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749689 | Eliquis 0.5 MG Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749690 | acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749690 | acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749690 | acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749691 | acetaminophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749691 | acetaminophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749691 | acetaminophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749692 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule) Pack | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | NO |
| RxCUI: 2749692 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule) Pack | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749692 | 1 daytime (acetaminophen 500 MG / dextromethorphan HBr 15 MG Oral Capsule) / 1 nighttime (acetaminophen 500 MG / dextromethorphan HBr 15 MG / doxylamine succinate 6.25 MG Oral Capsule) Pack | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749693 | isopentyl cyclohexyl acetate | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749693 | isopentyl cyclohexyl acetate | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749694 | apixaban 1.5 MG Dose Pack, 0.5 MG (84) Tablet for Oral Suspension | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2749694 | apixaban 1.5 MG Dose Pack, 0.5 MG (84) Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749694 | apixaban 1.5 MG Dose Pack, 0.5 MG (84) Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749695 | Eliquis 1.5 MG Dose Pack, 0.5 MG (84) Tablet for Oral Suspension | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2749695 | Eliquis 1.5 MG Dose Pack, 0.5 MG (84) Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749695 | Eliquis 1.5 MG Dose Pack, 0.5 MG (84) Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749697 | apixaban 2 MG Dose Pack, 0.5 MG (112) Tablet for Oral Suspension | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2749697 | apixaban 2 MG Dose Pack, 0.5 MG (112) Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749697 | apixaban 2 MG Dose Pack, 0.5 MG (112) Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749698 | Eliquis 2 MG Dose Pack, 0.5 MG (112) Tablet for Oral Suspension | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2749698 | Eliquis 2 MG Dose Pack, 0.5 MG (112) Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749698 | Eliquis 2 MG Dose Pack, 0.5 MG (112) Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749699 | apixaban 0.5 MG Dose Pack, 0.5 MG (28) Tablet for Oral Suspension | Generic Pack (GPCK) | {# (Ingredient + Strength + Dose Form) / # (Ingredient + Strength + Dose Form)} Pack | YES |
| RxCUI: 2749699 | apixaban 0.5 MG Dose Pack, 0.5 MG (28) Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749699 | apixaban 0.5 MG Dose Pack, 0.5 MG (28) Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749700 | Eliquis 0.5 MG Dose Pack, 0.5 MG (28) Tablet for Oral Suspension | Brand Name Pack (BPCK) | {# (Ingredient Strength Dose Form) / # (Ingredient Strength Dose Form)} Pack [Brand Name] | YES |
| RxCUI: 2749700 | Eliquis 0.5 MG Dose Pack, 0.5 MG (28) Tablet for Oral Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749700 | Eliquis 0.5 MG Dose Pack, 0.5 MG (28) Tablet for Oral Suspension | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749730 | iberdomide hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749731 | iberdomide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2749732 | salicylic acid 1.9 % Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749732 | salicylic acid 1.9 % Topical Solution | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749733 | iberdomide 0.75 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749734 | iberdomide Oral Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749735 | iberdomide Pill | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749736 | iberdomide Oral Capsule | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749737 | iberdomide 0.75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749737 | iberdomide 0.75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749737 | iberdomide 0.75 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749738 | Zenbexus | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749739 | iberdomide 0.75 MG [Zenbexus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749740 | Zenbexus Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749741 | Zenbexus Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749742 | iberdomide Oral Capsule [Zenbexus] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749743 | Zenbexus 0.75 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749743 | Zenbexus 0.75 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749743 | Zenbexus 0.75 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749744 | iberdomide 1 MG | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749745 | iberdomide 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749745 | iberdomide 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749745 | iberdomide 1 MG Oral Capsule | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749746 | iberdomide 1 MG [Zenbexus] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749747 | Zenbexus 1 MG Oral Capsule | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749747 | Zenbexus 1 MG Oral Capsule | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749747 | Zenbexus 1 MG Oral Capsule | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749799 | Dexvetra | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 27498 | Indecainide | Designated preferred name (PT) | NO | |
| RxCUI: 27498 | Indecainide | Full form of descriptor (FN) | NO | |
| RxCUI: 2749800 | dexmedetomidine hydrochloride 0.5 MG/ML [Dexvetra] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2749800 | dexmedetomidine hydrochloride 0.5 MG/ML [Dexvetra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749801 | Dexvetra Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2749802 | dexmedetomidine Injectable Solution [Dexvetra] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2749802 | dexmedetomidine Injectable Solution [Dexvetra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749803 | dexmedetomidine hydrochloride Injectable Solution [Dexvetra] | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749804 | DEXVETRA 0.5 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749804 | DEXVETRA 0.5 MG/ML Injectable Solution | Tall Man Lettering Synonym (TMSY) | Tall Man Lettering synonym of another TTY, given to distinguish between commonly confused drugs. | NO |
| RxCUI: 2749804 | DEXVETRA 0.5 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749804 | DEXVETRA 0.5 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749805 | robenacoxib 20 MG/ML [Ostirobe] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2749806 | Ostirobe Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2749807 | robenacoxib Injectable Solution [Ostirobe] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2749808 | OstiRobe 20 MG/ML Injectable Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749808 | OstiRobe 20 MG/ML Injectable Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749808 | OstiRobe 20 MG/ML Injectable Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749809 | dicyclanil | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749810 | dicyclanil 65 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | NO |
| RxCUI: 2749811 | dicyclanil Topical Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2749812 | dicyclanil Topical Suspension | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2749813 | dicyclanil 65 MG/mL Topical Suspension | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749813 | dicyclanil 65 MG/mL Topical Suspension | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749854 | Alysicarpus longifolius whole extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749855 | Codonopsis tubulosa root extract | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749856 | Gelsolin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 2749856 | Gelsolin | Designated preferred name (PT) | NO | |
| RxCUI: 2749856 | Gelsolin | Full form of descriptor (FN) | NO | |
| RxCUI: 2749940 | Fleaviate | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| RxCUI: 2749941 | nitenpyram 57 MG [Fleaviate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2749942 | Fleaviate Oral Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2749943 | Fleaviate Pill | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2749944 | nitenpyram Oral Tablet [Fleaviate] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2749945 | FleaViate 57 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749945 | FleaViate 57 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749945 | FleaViate 57 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749946 | nitenpyram 11.4 MG [Fleaviate] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2749947 | FleaViate 11.4 MG Oral Tablet | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749947 | FleaViate 11.4 MG Oral Tablet | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749947 | FleaViate 11.4 MG Oral Tablet | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749948 | moxidectin 5 MG/ML [Moxisolv] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | NO |
| RxCUI: 2749949 | Moxisolv Topical Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | NO |
| RxCUI: 2749950 | moxidectin Topical Solution [Moxisolv] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | NO |
| RxCUI: 2749951 | MoxiSolv Pour-On for Cattle 5 MG/ML Topical Solution | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749951 | MoxiSolv Pour-On for Cattle 5 MG/ML Topical Solution | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749951 | MoxiSolv Pour-On for Cattle 5 MG/ML Topical Solution | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749952 | garetosmab-grts | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | YES |
| RxCUI: 2749953 | Garetosmab | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 2749953 | Garetosmab | Designated preferred name (PT) | YES | |
| RxCUI: 2749953 | Garetosmab | Full form of descriptor (FN) | YES | |
| RxCUI: 2749953 | Garetosmab | Designated preferred name (PT) | YES | |
| RxCUI: 2749953 | Garetosmab | Full form of descriptor (FN) | YES | |
| RxCUI: 2749954 | garetosmab-grts 60 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749955 | garetosmab Injectable Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | YES |
| RxCUI: 2749956 | garetosmab Injection | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | YES |
| RxCUI: 2749959 | garetosmab-grts 300 MG in 5 ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749959 | garetosmab-grts 300 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749959 | garetosmab-grts 300 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749960 | garetosmab-grts 60 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749960 | garetosmab-grts 60 MG/ML Injection | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749961 | Pasatru | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 2749962 | garetosmab-grts 60 MG/ML [Pasatru] | Semantic Branded Drug Component (SBDC) | Ingredient + Strength + Brand Name | YES |
| RxCUI: 2749963 | Pasatru Injectable Product | Semantic Branded Dose Form Group (SBDG) | Brand Name + Dose Form Group | YES |
| RxCUI: 2749964 | garetosmab Injection [Pasatru] | Semantic Branded Drug Form (SBDF) | Ingredient + Dose Form + Brand Name | YES |
| RxCUI: 2749966 | PASATRU 300 MG in 5 ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | YES |
| RxCUI: 2749966 | PASATRU 300 MG in 5 ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749966 | PASATRU 300 MG in 5 ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749967 | PASATRU 60 MG/ML Injection | Semantic Branded Drug (SBD) | Ingredient + Strength + Dose Form + Brand Name | NO |
| RxCUI: 2749967 | PASATRU 60 MG/ML Injection | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749967 | PASATRU 60 MG/ML Injection | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749969 | menthol Nasal Product | Semantic Clinical Dose Form Group (SCDG) | Ingredient + Dose Form Group | NO |
| RxCUI: 2749970 | menthol Nasal Inhalant | Semantic Clinical Drug Form (SCDF) | Ingredient + Dose Form | NO |
| RxCUI: 2749971 | menthol 15 % Nasal Inhalant | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749971 | menthol 15 % Nasal Inhalant | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749971 | menthol 15 % Nasal Inhalant | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749972 | camphor 4 % / capsaicin 0.025 % / menthol 3 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749972 | camphor 4 % / capsaicin 0.025 % / menthol 3 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749972 | camphor 4 % / capsaicin 0.025 % / menthol 3 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
| RxCUI: 2749996 | lidocaine 41.2 MG/ML | Semantic Clinical Drug Component (SCDC) | Ingredient + Strength | YES |
| RxCUI: 2749997 | lidocaine 4.12 % Topical Spray | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | YES |
| RxCUI: 2749997 | lidocaine 4.12 % Topical Spray | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| RxCUI: 2749997 | lidocaine 4.12 % Topical Spray | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | YES |
| RxCUI: 2749998 | camphor 3 % / menthol 4 % / methyl salicylate 10 % Topical Cream | Prescribable Name (PSN) | Synonym of another TTY, given for clarity and for display purposes in electronic prescribing applications. Only one PSN per concept. | NO |
| RxCUI: 2749998 | camphor 3 % / menthol 4 % / methyl salicylate 10 % Topical Cream | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 2749998 | camphor 3 % / menthol 4 % / methyl salicylate 10 % Topical Cream | Semantic Clinical Drug (SCD) | Ingredient + Strength + Dose Form | NO |
